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Cellular glutathione (GSH) plays an important role in the regulation of cell 
proliferation and apoptosis, as well as in the detoxification of xenobiotics. GSH level 
is one of the major determining factors in the resistance of cancer cells against 
certain chemotherapeutic agents and radiotherapy. Depletion of GSH in cancer cells 
is an attractive strategy to sensitize cancer cells to different therapies. 
Baicalein and baicalin, which are the major flavonoids of Scutellaria 
baicalensis Georgi，often act as antioxidants to protect against oxidative stress. 
However, from our preliminary findings, baicalein and baicalin could undergo 
auto-oxidation to form semi-quinones and quinones respectively, which might react 
with sulfhydryl groups such as GSH. Therefore we have conducted this study to 
investigate whether baicalein and baicalin deplete GSH in vitro and inhibit cancer 




We have screened a total of 4 brain (U87-MG, U138-MG, NHA and HCN-2) 
and 4 liver (HepG2, Hep3B, BEL7404 and L02) cell lines for the growth-inhibitory 
and cytotoxic actions of baicalein and baicalin. From the 
3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) results, 
baicalein was more potent than baicalin and U87-MG (human astrocytoma) was the 
most sensitive cancer cell line towards baicalein treatment without significant 
cytotoxic effects on human normal astrocytes (NHA) and neurons (HCN-2). 
Baicalein depleted GSH in U87-MG cells in a dose- and time-dependent 
manner and GSH depletion was followed by cell death. The susceptibility of brain 
cancer cells to baicalein was found to be highly correlated with their intracellular 
GSH levels. 
Baicalein changed the mitochondrial membrane potential and caused 
phosphatidylserine exposure, which are the hallmarks for the early stage of apoptosis. 
Baicalein was found to activate caspase-8, -9 and -3 and induce DNA fragmentation. 
It also generated cellular and mitochondrial reactive oxygen species (ROS). These 
results demonstrated that baicalein induced U87-MG cell death via apoptosis. 
Interestingly, the cytotoxic and apoptotic actions of baicalein were 
significantly abrogated by the treatments of different antioxidants such as catalase 
ii 
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(CAT), glutathione ethyl ester (GEE), A^-acetylcysteine (NAC) and superoxide 
dismutase (SOD) with different extents. 
These results demonstrated that baicalein-induced astrocytoma apoptosis 
may be via a caspase-dependent pro-oxidant mechanism. From the above results, we 
proposed that baicalein generated cellular and mitochondrial ROS resulting in 
intracellular GSH depletion. This subsequently led to apoptosis. The correlation 
between GSH levels and drug susceptibility in this study gives us an insight on the 
treatment of brain cancers. Further studies in this direction may provide us with a 
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Chapter 1 Introduction 
Chapter 1 Introduction 
1. In t roduct ion-Cel lu lar Redox State and Cancer Biology 
1.1. Cellular Redox State and Cancer Biology 
Cellular redox state reflects the balance between the levels of oxidants and 
reductants and it is strictly regulated for normal cellular functions. If the homeostasis 
of redox state in cells is disturbed, oxidative stress occurs resulting in cellular 
damages such as lipid peroxidation, DNA cross-linking and protein inactivation. In 
the past few decades, oxidative stress is found to be closely associated with cancer 
development. 
1.2. Reactive Oxygen Species (ROS) 
Reactive oxygen species (ROS) have been implicated in different 
physiological processes such as cancer, aging, immune response, etc (Karihtala and 
Soini, 2007; McEligot et aL, 2005). ROS are either (i) free radicals, which are 
molecules with one or more unpaired electrons on their outermost orbitals such as 
1 
Chapter 1 Introduction 
superoxide radical anions (02*~) and hydroxyl radicals (OH*); or (ii) non-radicals 
such as hydrogen peroxide (H2O2) and hydroxyl anions (0H~). The life spans of 
different ROS are related to their reactivities. Free radicals have much shorter life 
spans than non-radicals because they are highly reactive and unstable and thus they 
have to react very rapidly with another radical to reach a more stable energy state. 
This often results in the initiation of a chain reaction (Locigno and Castronovo, 
2001). 
ROS are continuously generated during biological processes. During 
cellular respiration, oxygen molecules undergo a series of one-electron reductions 
with cytochrome c oxidase which is present in the electron transport chain of 
mitochondria to produce superoxide radical anions, hydrogen peroxide, hydroxyl 
radicals and water: 
e" — e—+ 2H+ + e^ + H. 
O2 • O2•“ • H2O2 • OH. • H2O 
H2O 
Superoxide radicals are generated by the electron transport chain in 
mitochondria. Due to the presence of a negative charge, it is unable to penetrate cell 
membranes and thus remains mainly in the mitochondria (Balendiran et al., 2004). In 
aqueous solution, superoxide radicals are hydrated to give hydroperoxyl radicals 
2 
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(HOO*) which are stronger oxidants than superoxide radicals. Normally, superoxide 
radicals undergo a dismutation reaction spontaneously or enzymatically to form 
hydrogen peroxide. (Karihtala and Soini, 2007; Locigno and Castronovo, 2001): 
2 O2•“ + 2 H+ • H2O2 + 02 
Although the dismutation reaction is a spontaneous process, it can be 
several orders of magnitude faster when catalyzed by the enzyme superoxide 
dismutase (SOD). Although superoxide radicals are more reactive than hydrogen 
peroxide, they cannot pass through cell membranes without the aid of an anion 
channel. In contrast, the more lipophilic hydrogen peroxide can readily pass through 
cell membranes and travel a long distance. Nevertheless, hydrogen peroxide can 
produce highly reactive hydroxyl radicals through the Haber-Weiss reaction: 
2 O2•一 + H2O2 • 02 + OH* + OH" 
The generation rate of hydroxyl radicals can be greatly enhanced in the 
presence of transition metal ion catalysts such as iron or copper, a process known as 
Fenton reaction (Balendiran et al., 2004): 
Fe3+ + O2•“ • Fe2+ + O2 
Fe^^ + H2O2 • Fe3+ + 0H. + 0 H -
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The hydroxyl radical is highly reactive. It reacts in vivo rapidly with most 
molecules around its formation site resulting in generation of other radicals such as 
peroxyl radical (ROO.) which is a propagator of lipid peroxidation. 
Under normal conditions, iron and copper do not exist in free forms within 
cells because iron and copper ions are strictly bound to proteins such as ferritin, 
transferrin etc (Balendiran et al., 2004). 
ROS can be destructive to cells. For instance, they oxidize and break up cell 
membranes by lipid peroxidation, cleave DNA and inactivate proteins. This 
subsequently results in cellular dysfunction and cell death. 
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1.3. Regulation of Cellular Redox State by Intrinsic and Extrinsic Antioxidant 
Systems 
Since mammalian cells are continuously exposed to endogenous ROS 
generated metabolically and exogenous ROS from the environment, mammals are 
evolved to develop intrinsic and extrinsic antioxidant systems to maintain cellular 
redox state normal and protect cells against oxidative stress (McEligot et al., 2005). 
Intrinsic antioxidant systems can be divided into enzymatic and 
non-enzymatic ones. Antioxidant enzymes include superoxide dismutase (SOD), 
catalase (CAT) and glutathione peroxidase (GPx). Non-enzymatic redox buffer 
systems include reduced/oxidized glutathione (GSH/GSSG) and 
thioredoxin/thioredoxin reductase (Trx/TR), and both systems involve 
thiol-containing groups. 
Extrinsic antioxidant systems including vitamin C, vitamin E, P-carotene 
and other carotenoids are often obtained from the diet. 
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1.3.1. Intrinsic Antioxidant System 
SOD catalyzes the dismutation of the highly reactive superoxide radicals to 
less reactive hydrogen peroxide. There are three types of SODs present in human 
cells. Manganese-containing SOD (Mn-SOD) is located in mitochondria, while 
copper- (Cu-SOD) and zinc-containing SOD (Zn-SOD) are located in the cytosol. 
Among mammalian tissues, liver possesses the highest SOD activity, followed by 
kidney, brain and heart. The distribution of various SOD types within cells vary from 
tissue to tissue (McEligot et al., 2005; Karihtala and Soini, 2007). 
CAT is a tetrameric heme protein which is mainly located in peroxisomes. 
It catalyzes the decomposition of hydrogen peroxide to water and oxygen molecules 
(Karihtala and Soini, 2007). 
2 H2O2 2 H2O + O2 
GPx is a selenium-containing enzyme which is located in both the cytosol 
and mitochondrial matrix of mammalian cells. The activities of GPx are the highest 
in liver and erthyrocytes. The brain, kidney and heart also possess moderate activities 
of GPx. GPx catalyzes the reduction of hydrogen peroxide into water at the expense 
of GSH, which is oxidized to form GSSG 
2 GSH + 2H2O2 今 GSSG +2 H2O 
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Reduction of GSSG back to GSH is catalyzed by glutathione reductase (GR) 
which is a flavin-containing enzyme while reduced (3-nicotinamide adenine 
dinucleotide phosphate (NADPH) is used as the reducing power. 
GSSG + NADPH + H+ 2 GSH + NADP+ 
GSH/GSSG system is one of the major regulators of cellular redox state to 
modulate cellular responses to redox changes. In brain, GSH/GSSG system is 
particularly important in controlling cellular redox states and is the primary defense 
mechanism for the removal of peroxide from the brain (Tanaka et aL, 2004). 
The Trx/TR system is a ubiquitous redox couple in both prokaryotes and 
eukaryotes. TR is a NADPH-dependent flavin adenine dinucleotide-containing 
enzyme. It works with Trx to maintain a reduced intracellular environment. 
Interconversion between oxidized and reduced forms of TR requires transfer of 
electrons from NADPH. The flavin adenine dinucleotide prosthetic group of TR 
donates the electrons from NADPH to cysteines in its active site, resulting in the 
catalytic active form of TR which reduces the active site cystine of oxidized Trx 
(McEligot et aL, 2005). 
Trx-(SH)2 + X-S2 • Trx-S2 + X-(SH)2 
(where X is sulfhydryl-containing protein) 
TR 
Trx-S2 + NADPH • Trx-(SH)2 + NADP+ 
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1.3.2. Extrinsic Antioxidant System 
Vitamin C 
Vitamin C functions as an antioxidant which reduces highly reactive 
radicals such as hydroxyl, peroxyl, superoxide radicals, singlet oxygen and reactive 
peroxides. Subsequently, the relatively less reactive ascorbyl radical is formed. The 
primary dietary sources for vitamin C are fruits and vegetables (McEligot et al” 
2005). 
Carotenoids 
Carotenoids protect cells from oxidative stress by several mechanisms. One 
of the main mechanisms is to quench singlet oxygen which is an electronically 
excited form of oxygen and is highly reactive. Carotenoids also interact with free 
radicals such as peroxyl or alkoxyl radicals. They act as electron donors to transfer 
electrons and reduce free radicals to less reactive carotenoid radical cations. The 
dietary availability of carotenoids is also mainly from fruits and vegetables. 
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1.4. Glutathione 
1.4.1. General Information on Glutathione 
glutamate H N H o 
I i 
‘ ― # 1 H N H ' I 〇 
O glycine 
cysteine 
Figure 1. The Structure of Glutathione 
Glutathione, which is also called L-y-glutamyl-Z-cysteinyl-glycine, is a 
water-soluble ubiquitous tripeptide composed of 3 amino acids: glutamate (Glu), 
cysteine (Cys) and glycine (Gly) (Marinou et ah, 2005). Glutathione is the most 
prevalent non-protein thiol and the most abundant low molecular weight peptide in 
mammalian cells in almost all tissues (Dringen, 2000). It exists in a reduced form 
(GSH) and two oxidized forms (GSSG disulfide and GSH mixed disulfide with 
protein thiols) and GSH is predominantly intracellular (Wu et al., 2004). The 
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GSH/GSSG system is the major redox couple in cells. The GSH + 2 GSSG 
concentration is usually denoted as total intracellular GSH, with a significant amount 
(up to 150/0) may exist as GSH mixed disulfide with protein thiols. The [GSH]: 
[GSSG] ratio acts as an indicator of cellular redox state. In normal physiological 
conditions，GSH/GSSG ratio ranges from 10 to 100, while in oxidative stress or other 
pathological conditions, the ratio reduces to a value between 1 and 10 (Estrela et al., 
2006). 
The total intracellular GSH concentration depends on a dynamic balance 
between the rate of GSH synthesis and the combined rate of GSH consumption 
within cells and loss through efflux. GSSG efflux from cells contributes to a net loss 
of intracellular GSH. Cellular GSH level decreases significantly in response to 
protein malnutrition, oxidative stress and other pathological conditions (Estrela et al， 
2006; Hall, 1999). 
GSH can be found in 0.5-10 milimolar level in most human tissues 
(Balendiran et al., 2004; Locigno and Castronovo, 2001), and high levels in brain 
because of its relatively high metabolic rate (Drake et al., 2002; Wu et al., 2004). 
Although glutamate and glycine are present in milimolar levels, cysteine is only in 
micromolar level. Therefore, the bioavailability of cysteine is rate-limiting for GSH 
synthesis. Cysteine, which is a sulfur-containing amino acid, has reducing and 
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nucleophilic properties (Drake et al., 2002). It is highly reactive because its disulfide 
bonds (S-S) and sulfhydryl groups (SH-) are particularly susceptible to the action of 
free radicals (Estrela et al., 2006). Due to the presence of Cys residues, GSH is thus 
readily oxidized non-enzymatically to GSSG by electrophiles such as reactive 
oxygen species and reactive nitrogen species (RNS). To maintain stable GSH/GSSG 
ratio, cells depend on glutathione reductase to reduce GSSG and regenerate GSH. 
In mammalian cells, the majority (around 90%) of intracellular GSH 
content is located in the cytosol while the minority (around 10%) in mitochondria 
and a very small percentage in the endoplasmic reticulum (ER) and peroxisomes. 
Extracellular GSH level is relatively low (only around 2-20 |LIM in plasma). 
Mitochondria rely highly on GSH to remove ROS due to its high respiration rate (Wu 
et al., 2004). Since GSH synthesis is mainly present in cytosol and mitochondria are 
incapable of de novo synthesis of GSH, GSH is transported from the cytosolic pool 
across the outer mitochondrial membrane into mitochondria, with co-transport of 
proton cations. However, the proton extrusion pumps form a steep electro-chemical 
gradient resulting in the net negative charge of the inner surface of the outer 
mitochondrial membrane. Since GSH is negatively charged at physiological pH, 
GSH transport into mitochondria is an active process. As mitochondrial GSH is 
important to protect against oxidative damage and to maintain cell viability, the 
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mitochondrial GSH level is preserved within physiological levels at the expense of 
energy, even when cytosolic GSH levels decrease (Sims et al,, 2004; Estrela et al, 
2006). 
1.4.2. Functions of Glutathione 
GSH plays important roles in various cellular functions. GSH is the main 
antioxidant and free radical scavenger to remove endogenous ROS generated during 
oxidative metabolism. GSH is essential for the maintenance of cellular redox state 
and different proteins in reduced and active states, for detoxification of exogenous 
electrophiles and xenobiotics, for storage and transport of cysteine, for regulation of 
protein and DNA expression through thiol-disulfide exchange mechanisms and for 
regulation of cell proliferation and apoptosis (Schnelldorfer et al., 2000; Estrela et al., 
2006; Wu et aL, 2004; Dringen, 2000). 
1.4.2.1. As an Antioxidant and Free Radical Scavenger 
Through direct or indirect pathways, GSH scavenges ROS and RNS. GSH 
reacts non-enzymatically with superoxide radical anions, nitric oxide (NO) or 
hydroxyl radicals by conjugation and direct quenching (Hwang et al., 2005). For 
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instance, GSH conjugates with NO to form an S-nitroso-glutathione adduct which is 
then detoxified by the Trx/TR system. In addition, GSH acts as an electron donor to 
reduce H2O2 and other peroxides with the aid of glutathione peroxidase and form 
GSSG. GSH is then regenerated from GSSG by GR. For the reactions catalyzed by 
GPx and GR, GSH is not consumed but recycled (Wu et al,, 2004). 
1.4.2.2. As a Detoxifier 
GSH reacts with different electrophiles, physiological metabolites and 
xenobiotics (including chemical carcinogens and anticancer agents) with the aid of 
glutathione S-transferase (GST). GSTs are one of the Phase II detoxification enzyme 
families which can be divided into 3 distinct members: microsomal, cytoslic and 
mitochondrial. Microsomal GST plays a key role in the metabolism of several 
hormones (including testosterone and progesterone), leukotrienes and prostaglandins 
(Estrela et aL, 2006). GSTs have broad substrate specificities. They catalyze the 
conjugation of GSH (S-glutathionylation) with different toxic compounds to form 
mercapturates while Glu and Gly residues are removed to form S-substituted Cys. 
Acetylation of the cysteinyl amino group can form a mercapturic acid which is 
readily excreted in the urine. However, the formation of glutathione-S-conjugates by 
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GST for detoxification of xenobiotics or drugs results in a net loss of intracellular 
GSH. Therefore, it is necessary to replenish GSH for GST-detoxification by 
re-synthesis from the constituent amino acids in contrast to its free radical 
scavenging role (Dringen, 2000; Estrela et al., 2006; Balendiran et al., 2004). 
1.4.2.3. As a Regulator of Cell Signaling 
GSH induces several transcriptional factors of specific genes by regulation 
of their redox states. Some transcriptional factors contain Cys residues in their amino 
acid sequence of their DNA-binding domains. These Cys residues are essential for 
recognition of the binding site through electrostatic interactions with specific DNA 
bases. Oxidation of the Cys residues would affect the inter- and intra-molecular 
disulfide bonds and change the conformation of the transcription factors. This may 
result in inhibition of binding of the transcription factors. For example, GSSG 
inhibits the binding of NF-KB and activator protein 1 (AP-1) (McEligot et al., 2005). 
The GSH/GSSG system helps to regulate the specific gene expressions. 
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1.4.3. Synthesis of Glutathione 
De novo synthesis of GSH from three amino acid precursors solely occurs 
in the cytosol and involves in two sequential ATP-requiring enzymatic steps (Estrela 
et al； 2006). The first step, which is rate-limiting, y-glutamyl-cysteine synthetase 
(GCS) uses glutamate and cysteine as substrates to form the dipeptide 
y-glutamyl-cysteine. The dipeptide is then combined with glycine catalyzed by GSH 
synthetase (GS) to form GSH. This pathway occurs in virtually all tissues, with the 
liver being the major producer and exporter of GSH (Hall, 1999). GSH synthesis is 
mainly regulated by GCS activity, Cys bioavailability and GSH feedback inhibition 
on GCS (Wu et al, 2004; Dringen, 2000). The feedback inhibition by GSH involves 
the redox state of sulfhydryl groups lying between the catalytic (heavy) and 
regulatory (light) subunits of GCS. When GSH levels are high, the regulatory 
sulfhydryls are reduced. Due to the allosteric effects on the catalytic site on the heavy 
subunit, the rate of formation of y-glutamyl-cysteine and thus GSH synthesis 
decrease (Locigno and Castronovo, 2001). 
1.4.4. Catabolism of Glutathione 
Catabolism of extracellular GSH or GSH conjugates is initiated by the 
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ectoenzyme y-glutamyl transpeptidase (GGT), which catalyzes the transfer of the 
y-glutamyl moiety of GSH or GSH conjugate to an acceptor molecule to generate the 
dipeptide cysteinylglycine (CysGly) or CysGly conjugate, respectively (Estrela et al,, 
2006; Dringen, 2000). The dipeptide formed in the transpeptidation is then 
hydrolyzed by dipeptidases to Cys and Gly, which are subsequently up-taken by cells 
and recycled for intracellular GSH synthesis. Cys and Gly can also be converted into 
5-oxoproline by y-glutamyl cyclotransferase (GCT) and 5-oxoproline is then 
converted to Glu by 5-oxoprolinase for GSH synthesis (Wu et al., 2004). Although 
y-glutamyl-cysteine is the substrate for both GGT and GCS，GSH synthesis by GCS 
is more favourable in mammalian cells due to its higher affinity and activity 
(Balendiran et al., 2004; Locigno and Castronovo, 2001). 
1.4.5. Transport and Uptake of Glutathione 
GSH is synthesized intracellularly and exported from cells. GSH export is 
important for inter- and intra-organ transfer of Cys moieties. One of the most 
important functions of GSH is to store Cys since it is extremely unstable 
extracellularly and rapidly auto-oxidized to cystine. The y-glutamyl cycle by GGT 
allows GSH to serve as a continuous source of Cys. Liver is the central organ for de 
novo GSH synthesis and inter-organ GSH homeostasis, with GSH efflux important 
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for plasma GSH and thiol-disulfide status. GSH is released from cells by 
carrier-mediated transporters and GGT catalyzes the formation of CysGly, which is 
broken down by dipeptidases to form free Cys and Gly. Free Cys is readily taken up 
by most cells for the synthesis of GSH or proteins, depending on the need of cells. 
Excess Cys are degraded for excretion. 
Organs with high levels of GGT activity such as kidney, lung and intestine 
can utilize plasma GSH. Inter-organ circulation of GSH is supported by relatively 
high GSH level in hepatic veins. In liver, GSH is released at high rates into bile and 
blood. GSH transport to bile serves for hepatic detoxification while to blood for 
delivery to other tissues. Essentially liver and kidney, but also spleen, erythrocytes 
and leukocytes participate in the inter-organ circulation of GSH. Efflux of GSH and 
GSH S-conjugates from different mammalian cells are mediated by multi-drug 
resistance proteins (MRPs). Most cell types have no direct systems to transport intact 
GSH into cells. Therefore, some malignant cancer cells are evolved to utilize an 
alternative pathway to ensure sufficient cysteine bioavailability. For instance, cancer 
cells such as in liver, lung, breast and ovary cancers have relatively high GGT 
expression to efficiently degrade plasma GSH to provide extra source of Cys for 
uptake and synthesis of intracellular GSH so as to support their rapid cell growth. 
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1.4.6. Glutathione in Cancer Biology 
1.4.6.1. Role of Glutathione in the Regulation of Carcinogenesis, Growth and 
Apoptosis of Cancer Cells 
1.4.6.1.1. Role of Glutathione in Carcinogenesis 
The primary formation of malignant cancers involves in three main stages: 
initiation, promotion and progression. 
Initiation 
Non-lethal DNA mutations accumulate and DNA repair is no longer 
functional. These result in the transformation of normal cells into pre-neoplastic 
cells. 
Promotion 
Pre-neoplastic cells rapidly increase in cell number with enhanced survival 
capacity such as increased cell proliferation rate and resistance to apoptosis. 
Progression 
Pre-neoplastic cells transform to neoplastic cells with significant changes in 
genomic and chromosomic instability. 
It is well proved that ROS generation results in (i) DNA damages which 
affect cell cycles, stress responses, detoxifying capacity against chemical carcinogens; 
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(ii) non-functional DNA repair; or (iii) mutation of specific genes resulting in 
activation of proto-oncogenes or inhibition of tumor suppressor genes which causes 
uncontrollable cell proliferation or dysfunctions in the apoptotic induction on 
abnormal cells, respectively. This subsequently leads to carcinogenesis (Estrela et al； 
2006). 
Excess ROS stimulate the expansion of initiated cell clones by regulating 
genes related to cell proliferation and apoptosis in the progression stage. For instance, 
hydrogen peroxide is able to degrade IKB, which inhibits NF-KB for regulation of 
cell growth and apoptosis. Hydrogen peroxide also activates protein kinase C, which 
regulates cell cycles. In addition, ROS induce activation and synthesis of activator 
protein 1 (AP-1), which modulates cell proliferation and apoptosis (Karihtala and 
Soini, 2007). 
Since oxidative stress causes carcinogenesis, GSH being an antioxidant, can 
protect against ROS and reduce the incidence of cancer development (Balendiran et 
al., 2004). In addition to oxidative stress, there are numerous factors for the initiation 
and development of cancer such as genetic, environmental and dietary influences. 
The contribution of genetic polymorphism to carcinogenesis has been investigated. 
Human cytosolic GSTs show a high polymorphism and can be sub-divided into 6 
classes on the basis of the sequence similarity and immunological cross-reactivity: 
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alpha (a), mu (ii), omega (co), pi (TC), theta (6) and zeta (Q. The expression levels of 
different isoforms of GSTs are tissue specific. It is suggested that GST polymorphism 
is associated with an increased risk of lung, bladder, gastric, colorectal, skin, breast, 
kidney and liver cancers. This may be because GSTs play important roles in phase II 
detoxification by catalyzing GSH conjugation to different electrophiles, which are 
often carcinogenic (Balendiran et al., 2004). 
1.4.6.1.2. Role of Glutathione in the Growth of Cancer Cells 
GSH is important in regulating DNA and protein synthesis and cancer cell 
proliferation. It has been shown that GSH levels may be associated with cancer 
growth. For instance, rapid GSH synthesis in Ehrlich ascites tumor (EAT) cells 
contributes to the high rate of cellular proliferation. In addition, buthionine 
sulfoximine (BSO), which inhibits GCS to deplete intracellular GSH, decreased the 
A549 human lung carcinoma cell growth rate in vivo. The regulation of cancer cell 
growth by GSH may attribute to its ability to react with critical Cys residues in 
growth-related proteins (Estrela et al., 2006). 
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1.4.6.1.3. Role of Glutathione in Apoptosis of Cancer Cells 
Oxidative stress exerts a significant effect on the onset and progression of 
apoptosis. Mitochondria are the major sites of ROS formation and the regulation sites 
of apoptosis. Cytochrome oxidase in the electron transport chain is highly susceptible 
to ROS attack. Inhibition of cytochrome oxidase by ROS increases mitochondrial 
superoxide radical formation and exacerbates oxidative stress resulting in impairment 
of the electron transport chain. This causes a loss of membrane potential and 
incompetence of permeability transition pores. GSH is one of the main ROS 
scavengers within mitochondria to protect against oxidative stress. In normal 
physiology, high levels of intracellular GSH maintain cytochrome C in a reduced 
state and prevent apoptosis. During GSH-limiting condition, cytochrome C is 
released from mitochondria and then oxidized. The accumulation of oxidized 
cytochrome C in the cytoplasm subsequently results in apoptosis (Jefferies et al, 
2003). 
The GSH/GSSG system acts as a homeostatic redox buffer and it is a 
first-line defense against ROS and RNS, which activate or inhibit cancer-related 
proteins through the interaction of critical Cys residues. For example, tumor 
suppressor protein p53 contains 12 Cys residues and oxidation of some of the 
essential residues inhibits p53 function. Therefore, GSH maintains the critical Cys 
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residues of p53 in a reduced form to induce apoptosis and prevent uncontrollable cell 
proliferation. Since p53 promotes apoptosis, the suppression of its activity allows 
cancer cells from escaping the p5 3-mediated apoptotic pathway. Therefore, 
resistance to apoptosis in some cancer cells attributes to mutated p53. 
Caspases, which are able to induce apoptosis, also contain some critical 
cysteine residues in their active sites and require sufficient GSH to prevent the 
oxidation of these residues and activation of the enzymes and thus prevents 
apoptosis. 
Apoptosis is either induced by ROS generation or by GSH depletion. 
Recent studies show that antioxidants prevent apoptosis through a redox-based 
mechanism. The protective role of GSH against apoptosis involves detoxification of 
ROS, modulation of cellular redox state and the subsequent redox-sensitive cell 
signaling pathways and the interaction with pro- and anti-apoptotic proteins. GSH 
levels in Bax (pro-apoptotic proteins) over-expressing cells are significantly reduced 
and the cells are sensitive to apoptosis. BSO significantly enhanced Bax-induced 
apoptosis in four non-small-cell lung cancer cell lines. This suggests that GSH may 
play a role in Bax-mediated apoptotic mechanisms. In addition, GSH depletion 
sensitizes Bcl-2 (anti-apoptotic proteins) over-expressing cells to apoptosis. GSH 
also prevents apoptosis through the inhibition of AP-24, an apoptotic protease, which 
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induces DNA fragmentation. 
1.4.6.2. Role of Glutathione in the Regulation of Metastasis 
Interaction of cancer cells with endothelial cells in the capillary beds is a 
critical step to initiate metastasis. The liver is a common site for metastasis 
development. The interaction of metastatic cancer cells with the hepatic sinusoidal 
endothelium (HSE) and Kupffer cells activates the local release of pro-inflammatory 
cytokines which promote cancer cell adhesion, invasion and proliferation (Estrela et 
al., 2006). 
There is a direct relationship between GSH levels, proliferative and 
metastatic abilities of cancer cells. A study showed that intraplenic inoculation of 
B16 melanoma (B16M) cells into C75BL/6J synergic mice induced metastatic foci 
formation by colonizing different organs (Estrela et al., 2006). However, the extent 
of metastasis was much more severe when B16M cells with high GSH levels were 
inoculated in vivo. Moreover, when B16M cells with low GSH content were 
pre-treated with glutathione ethyl ester (GEE), which readily enters cells and releases 
free GSH, their metastatic rate increased. This demonstrated that GSH may directly 
involve in regulating metastistic activity of cancer cells. 
23 
Chapter 1 Introduction 
1.4.6.3. Role of Glutathione in Cancer Resistance and Therapy 
1.4.6.3.1. Role of Glutathione in Cancer Resistance 
GSH levels in cancer cells are highly related to the sensitivity against 
cytotoxic anticancer drugs and ionizing radiations (Balendiran et al, 2004; Estrela et 
al” 2006). In the comparison to normal tissues, high GSH levels are found in many 
cancers with different degrees of multidrug or radiation resistance, e.g. melanoma, 
bone marrow, ovary, larynx, bladder, lung, colon, pancreatic and breast cancer 
(Schnelldorfer et al., 2000). It has been shown that there is an increase in GSH levels 
in melphalan-resistant murine L1210 cells. In ovarian cancer, GSH levels were 
increased 10-fold after development of resistance to alkylating agents when 
compared to biopsy samples taken before treatment. Elevated levels of GSH were 
also observed in squamous cell carcinoma of the lung cell lines which were resistant 
to 4-hydroxyfosfamide, cisplatin and methotrexate. This is probably because high 
GSH levels help to detoxify anticancer drugs with the aid of GST (Balendiran et al., 
2004). It was also demostrated that increased intracellular GSH and enhanced GST 
activity contributed to cisplatin resistance in lymphocytomas, lung cancers, 
osteosarcomas and bladder cancers (Locigno and Castronovo, 2001). 
Nevertheless, over-expression of GSTs is also associated with an enhanced 
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resistance to anticancer drugs via GSH conjugation and detoxification. Enhanced 
doxorubicin resistance of leukaemia K562 cells were shown to have increased levels 
of GSH and GST. GST expressions were also elevated in colon and breast cancers. In 
human glioma cell lines, high level of GST-TC protein expression correlates with 
enhanced resistance to vincristine-induced cell death. TER199, an analog of GSH to 
inhibit GST, significantly reversed the multidrug resistance protein 1 -mediated drug 
resistance for vincristine, doxorubicin, etoposide and mitoxanthrone (McEligot et al., 
2005). 
In addition, GCS，which is a rate-limiting enzyme in GSH synthesis, is 
highly expressed in most cases of malignant colon, lung, breast and liver cancers. It 
was demonstrated that L-phenylamine mustard-resistance of human prostate 
carcinoma cell line (DU-145) was associated not only with elevated GSH levels but 
also with increased activity of GCS. High GCS activity may allow enhanced GSH 
synthesis to support rapid cancer cell proliferation (Balendiran et al, 2004). 
1.4.6.3.2. Role of Glutathione in Cancer Therapy 
Recent reports demonstrated the relationship between GSH levels and 
responses towards various cancer therapies. Modulation of GSH levels may provoke 
different responses in normal and cancer cells towards chemotherapeutic agents and 
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this may provide GSH-based strategy for the protection of normal cells and 
sensitization of cancer cells to chemotherapeutic agents. For example, BSO, 
diethylmaleate (DEM) and 2-oxothiazolidine-4carboxylate (OTZ) sensitized cancer 
cell death by GSH depletion. Cancer cells with low GSH levels were much more 
sensitive to j -irradiation. 
In vitro studies on the human breast cancer cell line MCF7 and in vivo 
study in rat mammary tumors showed that treatment with OTZ, which decreases 
intracellular GSH levels, sensitized the tumors to the alkylating agent melphalan and 
increased its cytotoxicity compared with melphalan alone. 
BSO is also used to sensitize resistant human ovarian cancer cells to 
doxorubicin by decreasing GSH levels and enhancing its cytotoxicity. However, 
although BSO is applied in clinical phase II trial to treat cancers, BSO and other 
thiol-depleting agents are non-specific. Such a profound GSH depletion in vivo 
within cancer cells inevitably cause irreversible damages in most normal tissues 
(Estrela et al., 2006). Therefore, selective GSH depletion only in cancer cells may 
sensitize cancer cells to cytotoxic drugs or ionizing radiation without causing 
harmful effects to normal cells. 
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1.5. Aims of the Present Study 
Cancers have been a major health problem in the world and they are the 
major cause of death in Hong Kong. According to the statistics released in 2004 by 
the Hong Kong Hospital Authority, there are about 22,000 new cases of cancer 
reported annually. Therefore, the development of therapy specifically against cancers 
but not normal tissues is imperative. 
GSH is closely related to cancer biology and GSH depletion may provide a 
promising strategy to kill cancer cells. From our preliminary results, flavanoids of 
Scutellaria baicalensis Georgi (SbG) could conjugate to GSH. Thus, it is worth 
investigating whether the flavanoids could induce cancer cell death by GSH 
depletion. The aims of the present study are as follows: 
1. To investigate whether the flavanoids could deplete GSH in vitro, 
2. To screen different cancer cell lines for the highest drug susceptibilities with the 
least harmful effects on the corresponding normal cell types. 
3. To investigate the modes and the mechanism of drug-induced cancer cell death. 
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Chapter 2 In Vitro Study of Baicalein and Baicalin on 
Glutathione Depletion 
2. Baicalein and Baicalin Depleted GSH In Vitro 
2.1. Introduction 
2.1.1. Scutellaria baicalensis Geo rgi 
Scutellaria baicalensis Georgi (SbG), which is also called Huang-qin in 
Chinese and Ougon in Japanese (Zhang et al,, 1998)，possesses a high therapeutic 
value. It is commonly used in China, Korea, Taiwan and Japan as a folk herbal 
medicine to treat various diseases (Chen et al., 2001; Ikemoto et al., 2000). 
2.1.1.1. General Clinical Applications to Treat or Prevent Diseases 
Apart from cancer, which will be dealt with in a subsequent section, SbG 
has been used to treat stroke, allergic and inflammatory diseases, arteriosclerosis, 
chest discomfort, nausea, acute dysentery, jaundice and carbuncles (Huang et al” 
2004). It also shows antipyretic, anti-bacterial and anti-hypertensive (Li et al., 2005) 
and sedative properties (Gao et al, 2001). Its antioxidant and anti-inflammatory 
properties contribute to its therapeutic values. 
28 
Chapter 2 In Vitro Study of Baicalein and Baicalin on Glutathione Depletion 
2.1.1.2. As an Antioxidant and Free Radical Scavenger 
SbG possesses a high free radical scavenging activity and could inhibit lipid 
peroxidation in rat liver homogenate and in beef heart mitochondria (Shao et al， 
1999). Free radicals target on poly-unsaturated fatty acids of lipid bilayer membranes. 
This peroxidation may impair membrane integrity, increase membrane permeability, 
reduce membrane fluidity, inactivate membrane-bound enzymes and receptors or 
inhibit the signal transduction over the membrane. Being an antioxidant, SbG 
attenuated protein oxidation and apoptosis in neuronal cell lines (HT-22) (Choi et al, 
2002). 
Its antioxidant property is mainly due to the presence of various flavanoids 
with a number of phenolic hydrogen. In addition, flavanoids have a strong affinity 
for Fe2+ ions, which catalyze the initiation of free radical generation. Baicalein, one 
of the major flavanoids in SbG, has also been shown to attenuate lipid peroxidation in 
liver microsomes by chelating free iron (Choi et al,, 2002). 
29 
Chapter 2 In Vitro Study of Baicalein and Baicalin on Glutathione Depletion 
2.1.1.3. Long History for Treatment of Cancers with Obscure Mechanism 
Huang-Lian-Jie-Du-Tang (HLJDT)(黃蓮解毒湯)，which contains Coptis 
rhizoma, Phellodendron bark, Scutellaria baicalensis Georgi root and Gardenia 
fruits, has been used as a traditional Chinese medicine (TCM) to inhibit cancer cell 
proliferation and induce apoptosis in myeloma cells (Ma et al, 2005). Among the 
natural components, SbG was found to have the greatest contribution to the 
growth-inhibitory effect in myeloma cell lines U266 and ILKM2. SbG induced 
morphologic changes, decreased the mitochondrial membrane potential (MMP), 
released cytochrome C and activated caspase-9 and caspase-3. That demonstrated 
that HLJDT induced apoptosis in myeloma cells. In addition, SbG could either 
inhibit cancer cell growth or induce apoptosis in breast, liver, pancreatic, prostate and 
urothelial carcinoma cell lines. 
Nevertheless, SbG also selectively and effectively inhibited cancer cell 
proliferation of two human head and neck squamoun cell carcinomas (HNSCC) 
SCC-25 and KB in vitro and in vivo while it does not affect the cell viability of 
non-tumor cell lines (Ha-CaT). However, there is no induction of apoptosis by SbG 
in TUNEL and DNA fragmentation assays (Zhang et al., 2003). 
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Since SbG inhibits some cancer cell proliferation while induces apoptosis in 
other cancer cells, the mechanisms and the main effective components are still not 
well understood. Therefore, it is well worth investigating the anticancer effects and 
the possible mechanisms of SbG. 
2.1.1.4. Major Components 
The dried roots of SbG contain a number of flavonoids such as baicalin 
and its aglycone baicalein, wogonoside and its aglycone wogonin (Choi et al., 2002; 
Gao et al., 1999). 
Water soluble extract of SbG contains wogonin (51.5%), baicalein (35.6%) 
and baicalin (up to 20%) (Jang et al., 2003). These major components are 
poly-phenols. The antioxidant effectiveness of phenolic compounds may be related 
to their abilities to pass through cell membrane and their orientations in cell 
membranes. Flavonoids anchor to the polar heads of membrane phospholipids 
forming reversible physiochemical complexes. The degree of glycosylation is one of 
the factors that affect various properties of flavonoids, particularly their 
hydrophobicities. Flavonoids of SbG, without sugar moieties such as baicalein, are 
more lipid-soluble and more readily penetrate cell membranes (Shao et al., 1999; 
Shao et al., 2002). 
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2.1.2. Baicalein and Baicalin 
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Figure 2-1. The Structures of Baicalein and Baicalin 
Baicalein and baicalin are the two major flavonoids in SbG Baicalein 
(5,6,7-trihydroxy-2-phenyl-4-H-1 -benzopyran-4-one) is the most effective 
component of SbG in antioxidant or free radical scavenging properties. Baicalein 
scavenged ROS including superoxide, hydrogen peroxide and hydroxy 1 radicals. It 
also inhibited several oxidases such as xanthine oxidase and 12-lipoxygenase (Li et 
al., 2005; Lee et al” 2003; Huang et al., 2004). 
Baicalein has been widely used against various inflammatory diseases and 
infections of the respiratory and gastrointestinal tract for years. It also inhibited 
acetic acid-induced increase in vascular permeability in mice and reduced acute paw 
edema in rats (Li et al.’ 2005; Shao et aL, 1999). 
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Baicalin (5,6-dihydroxy-4-oxo-2-phenyl-4H-l-benzopyrane-7-yl-p-D-
glucopyanosiduronic acid) has been used to treat upper respiratory infections, 
diphtheria, scarlet fever, viral hepatitis, nephritis and dysentery (Hwang et al., 2005; 
Jang et al., 2003). Baicalin also possessed anticancer, anti-inflammatory and 
anti-allergic properties (Sun et al., 2004). Baicalin was found to inhibit cancer cell 
proliferation and induce apoptosis in several human prostate cancer cell lines (Akao 
et al” 2004; Marks et al., 2002; Sovak et aL, 2002; Chen et al,, 2001). The 
underlying mechanism of anticancer properties of baicalein and baicalin remains 
unclear. 
2.1.2.2. As an Antioxidant and Free Radical Scavenger 
Baicalein and baicalin act as antioxidants to scavenge hydroxyl radicals, 
DPPH radicals and alkyl radicals effectively (Lee et al., 2003; Gao et al., 1999) The 
scavenging property of an antioxidant is often associated with its ability to form 
stable radicals. Flavonoids, which can scavenge radicals effectively, usually give rise 
to stable semi-quinone or quinone radicals in alkaline solution. It was shown that 
baicalein and baicalin could form stable radicals in mild alkaline solution (Shao et al., 
2002). 
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Figure 2-2. The Structures of Baicalein and Baicalin Semi-quinone Radicals (Gao et 
al., 1999) 
Glycosylation of flavonoids reduces their antioxidant activities. The direct 
free radical scavenging activities of four flavonoids in SbG decrease in the order of 
baicalein > baicalin » wogonin > wogonoside (Gao et al, 1999). This may be due 
to the fact that the free radical scavenging activity of a poly-phenolic compound is 
related to the number and structure of phenolic hydrogen. Baicalein and baicalin, 
with o-tri or o-di-hydroxyl groups in their A rings, respectively, could form stable 
free radicals in alkaline solution and therefore, baicalein and baicalin are much better 
free radical scavenger than wogonin and wogonoside. Since baicalein possesses one 
more hydroxyl group than baicalin and glycosylation is present in baicalin，baicalein 
is the most effective antioxidant in SbG (Gao et al., 2001). 
Baicalein and baicalin inhibited lipid peroxidation of rat brain cortex 
mitochondria induced by Fe^"^-ascorbic acid (Gao et al., 2001). Baicalein strongly 
inhibited iron-dependent lipid peroxidation in microsomes and mitochondria. 
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Baicalein protected against oxidative damages by chelating free irons. By the 
inhibition of Fe^"^-catalyzed Fenton reaction, baicalein decreased the generation of 
hydroxyl radicals in the presence of H2O2 (Samudio et al, 2005; Zhao et al., 2006). 
baicalein and baicalin inhibited protein nitration and lipid peroxidation in liver 
homogenate and in HepG2 cells in a dose-dependent manner with the inhibition 
order decreasing from baicalein > baicalin > wogonin. 
2.1.3. Hypothesis: Baicalein and Baicalin Induce Cancer Cell Death Via 
Glutathione Depletion 
Cellular glutathione plays an important role in regulation of cell 
proliferation and apoptosis, as well as in the detoxification of anticancer drugs. GSH 
level is one of the major factors for the resistance of cancer cells against certain 
chemotherapeutic agents and radiotherapy. Therefore, depletion of GSH in cancer 
cells is an attractive strategy to sensitize cancer cells to different therapies. Baicalein 
and baicalin, which are the major flavonoids of Scutellaria baicalensis Georgi, often 
act as antioxidants to protect against oxidative stress. However, from our preliminary 
data, baicalein and baicalin underwent auto-oxidation to form quinones and 
semi-quinones, respectively, which could then react with sulfhydryl contents such as 
glutathione. Therefore, we have conducted the present study to investigate whether 
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baicalein and baicalin induce cancer cell death by glutathione depletion. 
2.2. Materials and Methods 
2.2.1. Chemicals 
Baicalein with a purity of 98%, baicalin hydrate with a purity of 95% and 
other common chemicals and reagents were purchased from Sigma-Aldrich (St. 
Louis, MO, USA), which were of analytical grade with the highest purity available. 
Baicalein and baicalin were prepared as stock solutions in DMSO at 100-fold of final 
concentration (final DMSO concentration never exceeded 1% in the final assays). 
2.2.2. Buffers and Solutions 
Rinsing buffer 
150 mM NaCl, 1 mM EDTA 
Homogenization buffer 
250 mM sucrose, 30 mM imidazole-HCl，the solution pH was adjusted to 7.4 
Assay buffer 
50 mM imidazole-HCl, 120 mM NaCl, 12.5 mM KCl, 5 mM MgCb, solution 
pH was adjusted to 7.4. 
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2.2.3. Animals 
Sprague-Dawley rats used in this study were approved by Animal Research 
Ethics Committee, The Chinese University of Hong Kong and were supplied by the 
Laboratory Animal Service Centre of The Chinese University of Hong Kong. 
2.2.4. Preparation of Rat Brain Microsomes 
Rat brain microsomes were prepared according to a reported method 
(Thompson et al., 1989). In brief, Sprague-Dawley rats (250 g body weight) were 
sacrificed by cervical dislocation. The cerebral cortexes were dissected and rinsed 
with ice-cold rinsing buffer. The brain tissues were dry-blotted and weighed, 
followed by homogenization in four volumes of ice-cold homogenization buffer (250 
mM sucrose, 30 mM imidazole-HCl, pH 7.4) by a Polytron PT-10-35 homogenizer. 
The resultant homogenate was centriftiged at 4,300 g for 15 min at 4°C. The 
supernatant was saved and centrifuged at 40,000 g for 1 h at 4°C. The pellets were 
resuspended in homogenization buffer by passing through a 21 g syringe needle for 6 
times. The protein concentration of the microsomes was determined by the method of 
Lowry (Lowry et al., 1951) using bovine serum albumin (BSA) as standard and 
subsequently adjusted to 5 mg/ml. The brain microsomes were frozen in liquid 
nitrogen and stored at -80�C for subsequent experiments. The stored microsomes 
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were thawed on ice before use. 
2.2.5. Glutathione Depletion Assay In Vitro and Thiol Depletion Assay in Rat 
Brain Microsomes 
Glutathione depletion assay and thiol depletion assay were modified from a 
standard method for the determination of protein thiols (Jocelyn, 1987). In brief, 40 
|iM reduced glutathione in the sucrose/imidazole buffer or brain microsomes 
(originally 5 mg/ml pre-treated with 0.66 mg/ml of SDS) was incubated with or 
without baicalein or baicalin in assay buffer for 30 min at 37°C. An equal amount of 
DTNB reagent containing 180 mM sodium phosphate buffer (pH 7.4), 2 mM EDTA， 
4% SDS and 0.2 mM DTNB was then added. After a flirther incubation for 5 min at 
37°C, the absorbance of the reaction mixture at 412 nm (A 412 nm) was measured. To 
eliminate the interference due to the colour of baicalein or baicalin, the reading was 
subtracted with a non-thiol blank (sucrose/imidazole buffer only) for each sample 
with different concentrations of baicalein and baicalin. 
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2.2.6. Statistical Analysis 
Results were expressed as the mean 士 S.D. Statistical comparison among 
different treatments was assessed with one-way ANOVA followed by Tukey's 
Multiple Comparison Test using the GraphPad Prism 3.0 (GraphPad Software Inc., 
San Diego, USA). * 尸-value < 0.05, ** 尸-value < 0.01, *** P-value < 0.001 as 
compared with the corresponding control group. Differences with 户-value less than 
0.05 were considered statistically significant. 
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2.3. Results 
2.3.1. Effects of Baicalein and Baicalin on Sulfhydryl Contents of Glutathione 
DTNB, which is also called Ellman's reagent, is a well-known reagent for 
sulfhydryl group determination. DTNB has little or no absorbance, however, when it 
reacts with sulfhydryl contents to form 2-nitro-5-thiobenzoate anion (TNB^'), it gives 
an intensive yellow colour at A 412 nm. Therefore, if the amount of sulfhydryl contents 
decreases in the sample, the rate of formation of TNB ‘ decreases resulting in low 
absorbance. 
Without pre-incubation, baicalein or baicalin did not significantly reduce 
the amount of the DTNB-detectable sulfhydryl contents because there were no 
significant drops of the absorbance in baicalein- or baicalin-treated samples. These 
demonstrated that the colour of baicalein (up to 100 JUM) or baicalin (up to 1000 |LIM) 
did not interfere the absorbance readings and only a very small decrease of the 
absorbance was observed for high concentration of baicalin (greater than 1000 )j,M). 
Pre-treatment of baialein or baicalin for 30 min was shown to significantly 
deplete sulfhydryl contents of glutathione in a dose-dependent manner when 
compared with the groups without pre-incubation (Figure 2-3). However, baicalein 
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Figure 2-3. Effects of Baicalein and Baicalin on the DTNB-detectable Sulfhydryl 
Contents of GSH. One group of GSH (40 |LIM) was pre-incubated with (a) baicalein, 
(b) baicalin for 30 min while another group of GSH (40 |iM) was treated with the 
drugs without pre-incubation and directly added with DTNB. After pre-incubation, 
DTNB was added to the reaction mixture and incubated for further 5 min for the 
development of intense yellow colour. The absorbance of the reaction mixture at 412 
nm (A 412 nm) was then measured. 
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2.3.2. Effects of Baicalein and Baicalin on Sulfhydryl Contents of Rat Brain 
Microsomes 
Without pre-incubation, baicalein or baicalin did not significantly reduce 
the amount of the DTNB-detectable sulfhydryl contents because there were no 
significant decreases of the absorbance in baicalein- or baicalin-treated samples. 
These also demonstrated that the colour of baicalein (up to 100 pM) or baicalin (up 
to 500 |iM) did not interfere the absorbance readings and only a very small decrease 
of the absorbance was observed for high concentration of baicalin (greater than 500 
Pre-incubation of rat brain microsomes with baicalein or baicalin for 30 
min significantly depleted sulfhydryl contents in a dose-dependent manner when 
compared with the groups without pre-incubation (Figure 2-4). This showed that 
both baicalein and baicalin were able to conjugate to the sulfhydryl contents on 
membrane surfaces. Similarly, baicalein was more potent (around 10-fold) than 
baicalin to deplete sulfhydryl contents in microsomes. These findings were consistent 
to the results for depletion of sulfhydryl contents in glutathione. 
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Figure 2-4. Effects of Baicalein and Baicalin on the DTNB-detectable Sulfhydryl 
Contents of Rat Brain Microsomes (0.5 mg/ml). One group of rat brain microsomes 
(0.5 mg/ml) was pre-incubated with (a) baicalein, (b) baicalin for 30 min while 
another group of rat brain microsomes (0.5 mg/ml) was treated with the drugs 
without pre-incubation and directly added with DTNB. After pre-incubation, DTNB 
was added to the reaction mixture and incubated for further 5 min for the 
development of intense yellow colour. The absorbance of the reaction mixture at 412 
nm (A 412 nm) was then measured. 
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2.4. Discussion 
Effects of Baicalein and Baicalin on Sulfhydryl Contents of Glutathione and Rat 
Brain Microsomes 
Baicalein and baicalin depleted sulfhydryl contents in both glutathione and 
rat brain microsomes in a dose-dependent manner. However, baicalein was found to 
be a much more potent than baicalin to deplete sulfhydryl contents. 
There are two possible reasons for the higher potency of baicalein to 
deplete sulfhydryl contents. First, the glucuronic group in A ring of baicalin may 
induce steric hindrance to impede its conjugation against sulfhydryl contents. Second, 
under mild alkaline condition, the quinone formation of baicalein is more favourable 
than semi-quinone formation of baicalin and it was suggested that glucuronic acid of 
baicalin could prevent further oxidation of the baicalin semi-quinone radical to a 
quinone (Woo et al, 2005). Thus baicalein quinones readily form stable radicals to 
conjugate to sulfhydryl contents (see Section 2.1.2.2). Therefore, higher 
concentration of baicalin might be required to deplete the same amount sulfhydryl 
contents. 
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and Normal Cells 
Chapter 3 Effects of Baicalein and Baicalin on Proliferation 
of Different Human Cancer and Normal Cells 
3. Baicalein, but not Baicalin, Inhibited Human Cancer Cell 
Proliferation without Affecting Cell Proliferation on Human 
Normal Cells 
3.1. Introduction-Importance of Developing A Novel Compound Inducing 
Cancer Cells to Death with the Least Side Effects on Normal Cells 
Depletion of GSH is an attractive strategy for sensitization of cancer cells 
with thiol-mediated drug resistance to therapy. It was reported that BSO acted as an 
adjuvant chemotherapy for photosensitizing radiotherapy. In addition, BSO enhanced 
the cytotoxicity of a variety of anticancer drugs. However, BSO was also cytotoxic to 
normal cells and caused severe side effects in patients. Therefore, it is important to 
find a novel anticancer drug to sensitize cancer cells to death via GSH depletion and 
causes the least cytotoxic effects for normal cells with higher GSH (Samudio et al., 
2005). 
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3.2. Materials and Methods 
3.2.1. Instruments 
ELISA microplate reader (Bio-Rad Laboratories, Inc., USA) 
3.2.2. Chemicals and Cell Culture Reagents 
a-MEM, DMEM, PS, trypsin-EDTA were purchased from Gibco Co. 
(USA). All culture flasks, dishes, plates and pipettes were purchased from Iwaki 
(Japan). 
3.2.3. Buffers 
Phosphate-buffered saline (PBS) 
145 mM sodium chloride, 2 mM potassium chloride, 4 mM monobasic sodium 
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3.2.4. Cell lines 
U87-MG (human astrocytoma, grade III) was kindly provided by Dr. Jesse 
C.S. Pang, the Department of Anatomical and Cellular Pathology, The Chinese 
University of Hong Kong. U138-MG (human astrocytoma, grade IV also called 
glioblastoma) was a generous gift from Mr Samuel Ng, the Institute of Molecular 
Biology, The University of Hong Kong. Hep3B (human hepatoma) was a kind gift 
from Professor K.R Fung, the Department of Biochemistry, The Chinese University 
of Hong Kong and HepG2 (human hepatoma, No. HB-8065) was purchased from the 
American Type Culture Collection (ATCC, Rockville, MD，USA). BEL7404 (human 
hepatoma) and L02 (normal human liver cells) were kindly provided by Dr. Y.C. 
Chen, the Department of Medicine and Therapeutics, The Chinese University of 
Hong Kong. HCN-2 (human non-cancer cortical neurons) was kindly provided by 
Professor Mary M.Y. Waye, the Department of Biochemistry, The Chinese University 
of Hong Kong. Normal human astrocytes (NHA) were purchased from Cambrex, 
Clonetics-BioWhittaker (San Diego, CA). These primary astrocytes were established 
from normal human brain tissues and were cryo-preserved after secondary passage. 
NHA cultures within 10 passages were used for all the experiments. 
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3.2.5. Cell Culture 
U87-MG and U138-MG were maintained in complete culture medium 
consisting of a-MEM, supplemented with 10% FBS, penicillin (100 units/ml) and 
streptomycin (100 |ig/ml). HCN-2, HepG2, Hep3B, BEL7404 and L02 were 
maintained in complete culture medium consisting of DMEM，supplemented with 
10% FBS, penicillin (100 units/ml) and streptomycin (100 |Lig/ml). NHA were 
maintained in special Astrocyte Basal Medium (Clonetics-Bio Science Whittaker Inc.) 
supplemented with recombinant human epidermal growth factor (10 jig/ml), insulin 
(10 mg/ml), Z-glutamine, ascorbic acid, gentamicin (50 mg/ml), amphotericin (50 
|ag/ml) and 3% FBS. The astrocytes were sub-cultured according to the 
manufacturer's instructions. All cell types were maintained at 37°C in a humidified 
atmosphere of 5% CO2 and 95% air. 
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and Normal Cells 
3.2.6. Determination of Cell Proliferation by MTT Assay 
The 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
cell proliferation assay is a colorimetric assay to measure the reduction of a 
tetrazolium salt into an insoluble purple-blue formazan product by metabolically 
active succinate dehydrogenases within mitochondria of viable cells, but not in dead 
cells or their cell debris. After incubation of cells with MTT for 2-4 h, depending on 
the metabolic rates of different cell lines，DMSO is added to lyse the cells and to 
solubilize the purple-blue crystals. The absorbance at 540nm (A540 nm) is determined 
and the absorbance is directly proportional to the number of viable cells. 
Five thousand cells per well for U87-MQ U138-MG, HepG2, Hep3B, 
BEL7404 and L02 in 200 jil/well were seeded in a 96-well plate and allowed to 
grow overnight (24 h) to achieve about 80% confluence. For the two normal brain 
cell lines, NHA and HCN-2, 1000 cells per well for in 200 jal/well were seeded in a 
96-well plate and allowed to grow 48 and 72 h, respectively to achieve about 80% 
confluence. The cells were treated with control vehicle (DMSO) and different 
concentrations of baicalein and baicalin for different periods of time. After treatment, 
the media were removed and the cells were washed with PBS for twice. Fifty [i\ 
MTT (5 mg/ml in PBS) was added per well and incubated in dark at 37°C for 2-4 h. 
DMSO (150 \x\) was added to each well and incubated in dark at room temperature 
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for 30 min or until the purple-blue formazan products completely dissolve. The 
absorbance at 540 nm (A 540 nm) was measured by ELIS A microplate reader (Bio-Rad 
Laboratories, Inc., USA). Blank was performed by adding 50 [xl MTT and 150 |al 
DMSO only. Experiments were performed in five repeats and the percentage of cell 
proliferation (% of control) was calculated by the following equation: 
( O D t e s t s a m p l e - O D blank) 
% of control = X100% 
( O D c o n t r o l - O D blank) 
By definition, the proliferation of the negative control cells (DMSO-treated) 
was defined as 100%. 
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3.3. Results 
3.3.1. Anti-Proliferative Effects of Baicalein and Baicalin on Different Cancer 
Cell Lines 
DMSO (final concentration not greater than 1%), which was used as control 
vehicle, did not affect the proliferation of any cell lines investigated throughout the 
treatment. 
Baicalein significantly inhibited U87-MG (Figure 3-la) and U138-MG 
(Figure 3-lb) astrocytoma cell proliferation in a dose- and time-dependent manner. 
The effective dose of baicalein to obtain 50% inhibition of cell growth ( E D 5 0 ) was 
found to be 50 ^M for U87-MG (2-day treatment) and 100 jiM for U138-MG (6-day 
treatment). 
Baicalein only inhibited HepG2 (Figure 3-2a) and Hep3B (Figure 3-2b) in a 
high concentration (around 150 fiM) for longer treatment time (6-day treatment), 
however, no significant effects on BEL7404 cell proliferation was observed (Figure 
3-2c). The dose of baicalein required for 50% growth inhibition varied among the 
cell lines, with U87-MG being the most sensitive. 
In contrast, baicalin did not significantly inhibit cell proliferation of HepG2 
or Hep3B and E D 5 0 of baicalin for U87-MG was found to be greater than 150 jiM for 
2-day treatment (Figure 3-3). Since the cell lines investigated were not sensitve to 
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baicalin treatment, neither the subsequent experiments with longer treatment nor its 
cytotoxic effects on corresponding normal cells were performed. 
It was interesting to note that at low concentration of baicalein or baicalin 
with short treatment time may induce cancer cell proliferation to a small extent 
(Figures 3-la, 3-2b，3-2c and 3-3). 
The above results were comparable to the glutathione and thiol depletion 
findings that baicalein was coincidently found to possess a higher inhibitory effect on 
cancer cell proliferation than baicalin. 
Since baicalein was much more potent in inhibiting cancer cell proliferation 
than baicalin, only the cytotoxic effects of baicalein towards normal brain and liver 
cells were further investigated. 
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Figure 3-1. Anti-proliferative Effects of Baicalein on Different Human Astrocytoma 
Cell Lines, (a) U87-MG and (b) U138-MG cell lines were treated with control 
vehicle (DMSO), or indicated concentrations of baicalein for corresponding period of 
time. After treatment, the cell proliferation was assessed by MTT as described in 
Methods (Section 3.2.6). 
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Figure 3-2. Anti-proliferative Effects of Baicalein on Different Human Hepatoma 
Cell Lines, (a) HepG2, (b) Hep3B and (c) BEL7404 cell lines were treated with 
control vehicle (DMSO), or indicated concentrations of baicalein for corresponding 
period of time. After treatment, the cell proliferation was assessed by MTT as 
described in Methods (Section 3.2.6). 
54 
Chapter 3 Effects of Baicalein and Baicalin on Cell Viabilities of Different Human Cancer 
and Normal Cells 
150- — ^ U87-MG 
_ 125- I J … H e p G 2 
2 ^ r Hep3B 
芒 t \ 一 — I 
8 、 i 一 一 - … — — … ： -
咨 50 - ^ 
25 -
0H 1 1 1 1 1 1— 
0 25 50 75 100 125 150 
[Baicalin] (^M) 
Figure 3-3. Effects of Baicalin on Different Cancer Cell Lines. U87-MG, HepG2 and 
Hep3B were treated with control vehicle (DMSO), or indicated concentrations of 
baicalin for 2-day treatment. After treatment, the cell proliferation was assessed by 
MTT as described in Methods (Section 3.2.6). 
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3.3.2. Effects of Baicalein on Different Normal Cell Lines 
According to the results of MTT assay, baicalein only exhibited little 
cytoxicity towards NHA (normal human astrocytes) (Figure 3-4a) even at a high 
concentration of baicalein (150 ！jM) for long period of treatment time (6-day 
treatment). For 3-day treatment, baicalein also did not affect cell proliferation of 
HCN-2 (human non-cancer cortical neurons) (Figure 3-4b). There was also no 
significant inhibition for L02 (human normal liver cells) proliferation, however, 
baicalein could inhibit L02 cell proliferation for about 60% at high concentration 
(150 |jM) for 6-day treatment. 
These results demonstrated that baicalein did not exert cytotoxic effects on 
normal brain and liver cells. 
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Figure 3-4. Effects of Baicalein on Cell Proliferation of Human Normal Brain and 
Liver Cell Lines, (a) NHA, (b) HCN-2 and (c) L02 cell lines were treated with 
control vehicle (DMSO), or indicated concentrations of baicalein for corresponding 
period of time. After treatment, the cell proliferation was assessed by MTT as 
described in Methods (Section 3.2.6). 
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3.4. Discussion 
3.4.1. Anti-Proliferative Effects of Baicalein and Baicalin on Human Cancer 
Cells 
Baicalein exerted a higher cancer cell growth inhibitory effect than baicalin. 
This was consistent to the glutathione and thiol depletion assays that baicalein was 
more potent to deplete sulfhydryl contents in glutathione and in rat brain microsomes. 
One of the possible reasons might be that baicalein is more lipid-soluble and thus 
more readily across cell membrane to exert its growth inhibitory effect. In addition, 
baicalein forms quinone more readily to conjugate to GSH (Woo et al., 2005). This 
may also contribute to the higher growth inhibitory effect of baicalein. 
It was observed that baicalein induced U87-MG and Hep3B cell 
proliferation at low concentration (25 pM) in 2-day treatment, as well as BEL7404 at 
any concentrations in 3- to 6-day treatments. The main underlying mechansim for 
this observation may be on the basis of different antioxidant defense systems in 
different cell lines. Since it was suggested that oxidized baicalein quinones instead of 
reduced baicalein acted as a pro-oxidant by conjugating to GSH (Woo et al,, 2005), 
cell lines with a higher antioxidant potential may be more capable of reducing 
oxidized baicalein quinone back to its parent form and thus may be more resistant to 
cytotoxic actions of baicalein. Therefore, baicalein acting as proliferative or 
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anti-proliferative depends on whether baicalein concentration is high enough to 
overcome the particular antioxidant defense system in the specific cell lines. Low 
concentration of baicalein may not be sufficient to induce devastating GSH depletion 
and overcome the antixidant system resulting in cell death. Instead, low 
concentration of baicalein may just slightly decrease GSH and this may trigger a 
pre-conditioning effect to up-regulate GSH metabolism. This subsequently might 
result in increased GSH synthesis to support the rapid cancer cell growth and 
therefore, baicalein may act as an antioxidant to support fast-growing cancer cells. In 
contrast, high concentration of baicalein may deplete GSH significantly and the 
antioxidant system is no longer capable of replenishing the devastating effect and 
thus, baicalein may act as a pro-oxidant at high concentration. 
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3.4.2. Effect of Baicalein on Cell Proliferation on Different Human Normal Cell 
Lines 
Baicalein was found to be more potent to inhibit astrocytoma cell 
proliferation than hepatoma with the least cytotoxic effects on human normal 
astrocytes and neurons. It is well worth investigating the underlying principles for the 
differential susceptibilities of different normal and cancer cell lines towards baicalein 
treatment. Since GSH is one of the major factors for cell proliferation and apoptosis, 
basal GSH levels in different cell lines would be determined to prove whether GSH 
levels may contribute to the drug susceptibilities. 
In addition, since U87-MG was found to be the most sensitive cell line 
towards baicalein treatment, the underlying mechanisms of baicalein-induced cell 
death in U87-MG were further investigated. 
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Chapter 4 Glutathione-Depleting Effects of Baicalein on 
Cell Proliferation of Different Cell Lines 
4. Baicalein Depleted Cellular Glutathione (GSH) Prior to Inducing 
Cell Death and GSH Levels in Different Cell Lines were Related 
to the Susceptibilities of Baicalein Treatment. 
4.1. Introduction-Brain Tumors 
4.1.1. Types and Classifications of Brain Tumors 
Brain tumors are classified into primary or secondary brain ones, which are 
also known as metastatic cancers. Primary brain tumors are sub-divided into benign 
and malignant. Secondary brain tumors originate from primary tumors, from other 
tissues to brain by either direct extension or hematogenous spread. Primary brain 
tumors account for about 25% of the central nervous system (CNS) tumors and 
malignant astrocytomas (including anaplastic astrocytomas and glioblastomas) 
account for more than 50% of primary brain tumors (Lemke, 2004). 
The most widely accepted pathological grading system in the world for 
brain tumors is the World Health Organization (WHO) grading system (Walker and 
Kaye, 2001). The WHO classifies primary brain tumors by their cell types and grades 
them on a scale of I to IV on the basis of their rate of mitotic changes and the 
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presence of necrosis and pleomorphism. The higher the grade is, the more aggressive 
and malignant the tumor is. According to the latest revision of WHO classification in 
2000，tumors from neuroepithelial tissue include astrocytic tumors, mixed gliomas， 
oligodendroglial tumors, ependymal tumors, choroids plexus tumors, neuroepithelial 
tumors of uncertain origin, neuronal and mixed neuronal-glial tumors, embryonal 
tumors, pineal and parenchymal tumors. The classification has been updated in 
November 2006 and a new classification of CNS tumors will be published in the late 
2007. 
Astrocytic tumors (also called astrocytomas), which result from an 
abnormal hyper-growth of astrocytes, are the most common primary brain tumors. 
Astrocytes are glial cells, which function as an important supportive component of 
blood brain barrier (BBB). Astrocytomas account for about 75% of primary 
malignant brain tumor cells. These neoplasms are characterized by high recurrence 
rate and short survival time of the patients (Lemke, 2004; Collins, 2002). The WHO 
grading system in 2000 recognizes four different astrocytoma grades according to the 
tumor malignancies on histological features: 
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Grade I Astrocytomas 
Grade I astrocytomas include pilocytic astrocytomas and subependymal 
giant cell astrocytomas. They are the least malignant and considered as benign 
because of their low incidence of brain infiltration or distant spreads. They are 
usually well-defined and show a wide spectrum of morphologies (Michotte et al.’ 
2004). 
Grade II Low-Grade Astrocytomas (LGA) 
LGA are slow-growing astrocytic neoplasms with a high degree of cellular 
differentiation that diffusely infiltrate nearby brain tissues and tend to progress to 
high-grade astrocytomas (Michotte et al, 2004). LGA must be differentiated from 
pilocytic astrocytomas (Grade I) and primarily affect young adults. These subtypes of 
astrocytomas are commonly described as (i) fibrillary, which is most frequent variant 
of LGA; (ii) gemistocytic, which is occasional or regional occurrence; and (iii) 
protoplasmic astrocytomas, which is a rare variant composed of astrocytes showing 
small cell bodies with a low content of glial filaments. LGA are relatively defined 
mass, but when the malignancies increase, the infiltration and invasiveness of the 
tumors increase (Jiang et al., 2003). 
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Grade III Anaplastic Astrocytomas 
The anaplastic astrocytomas are within either focal or diffuse area and show 
anaplastic, mitotic and poorly differentiated astrocytes by histological testing. These 
tumors appear as well-defined masses on magnetic resonance imaging (MRI) with 
little or no edema. 
Grade IV Gliobalstomas 
Glioblastomas are highly infiltrative tumors with unclear boundaries and 
show anaplastic and poorly differentiated mitotic cells with areas of vascular 
hyperplasia and focal areas of necrosis by histological testing. About half of primary 
brain tumors are glioblastomas. They are the most common and malignant form in 
adults. Glioblastomas commonly occur in the frontal lobes within the white matter. 
These tumors infiltrate the surrounding brain tissues, frequently crossing the midline 
via the corpus callosum. When the tumors grow necrotic, they shunt blood supply to 
the younger tumor cells to enhance the cellular growth and the extensive infiltration 
capacity. Necrosis leads to a build-up of waste products and edema. Patient survival 
from the time of diagnosis to modem treatment is less than one year. Most recurrence 
(around 80%) occurs within a 2- to 3-cm margin surrounding the original tumors, 
with a mean survival after recurrence of just 4 to 5 months. 
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4.L2. Incidence Time, Patient Survival Time and Rate for Astrocytomas 
Primary CNS tumors account for around 1.35% of all cancers. 
Astrocytomas represent 42% of all primary CNS tumors and over three quarters are 
malignant in US (Reardon et al.，2006). 
Pilocytic astrocytomas (Grade I), which most commonly occur mainly in 
cerebellum of children, are generally biologically non-aggressive. They usually 
maintain their grade I status over years even decades and only very rarely progress to 
more malignant tumors. Adult diffuse astocytomas, which include the low-grade 
astrocytomas (Grade II), anaplastic astrocytomas (Grade III) and glioblastomas 
(Grade IV), frequently show malignant progression (Jiang et al, 2003; Collins, 
2002). 
The peak incidence for astrocytomas is in young adult between the age of 
30 and 40. Around 10% occur below the age of 20 years, 60% between 20 and 45 
years of age and about 30% over 45 years. There is a slight predominance in males 
(around 60%). 
The mean survival time for patients with low-grade astrocytomas (Grade II) 
is approximately 6-8 years, with anaplastic astrocytomas (Grade III) is around 3 
years and glioblastomas (Grade IV) is less than 1 year. 
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Patient survival rate with malignant astrocyomas remains low. Five year 
survival is 29.7% for anaplastic astocytomas and just 3.4% for glioblastomas. Almost 
all patients with astrocytomas eventually succumb to this deadly form of cancer 
(Collins, 2004). 
4.1.3. Symptoms and Diagnostic Methods for Brain Tumors 
When the brain tumors progress, the patients are severely affected, such as 
defects in higher cognitive functions, autonomy maintenance and decision-making 
ability. In addition, primary high-grade astrocytomas and metastatic brain tumors are 
devastating forms of cancer. Therefore, there is an immediate need to find an 
effective treatment for brain tumors (Lemke, 2004). 
There are several diagnostic methods for brain tumors such as magnetic 
resonance imaging (MRI), computed tomography (CT) scanning, and positron 
emission tomography (PET) (Walker and Kaye, 2001). 
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4.1.4. Treatments, Side Effects and Difficulties of Treatments for Brain Tumors 
Regarding the treatment for brain tumors, surgery remains the primary and 
main treatment because surgery supplies a tissue sample for histological analysis and 
thus it provides some insights for the treatment plan and prognosis. Although total 
resection may be the best treatment for brain tumors, less than 10% astrocytoma 
patients could receive total resection surgery due to unclear boundaries between 
tumors and normal tissues. Therefore, radiotherapy is applied complementary to 
surgery. Radiotherapy can be in the form of high dose focused-beam radiation, such 
as gamma knife. The area of radiation is applied on a ring of around 3 cm 
surrounding the tumors. However, there are a number of side-effects for radiotherapy, 
including hair loss, skin irritation, fatigue and loss of appetite (Lemke, 2004). 
Chemotherapy has long been an alternative to treat brain tumors. The most 
common chemotherapeutic agents for brain tumors are 
1,3-bis(2-chloroethyl)-1 -nitrosourea) (BCNU), CCNU (lomustrine), procarbazine, 
methotrexate and streptozocin, which all are given intravenously. Temodar 
(temozolomide) is an oral chemotherapeutic agent for anaplastic astrocytomas 
progressed after radiotherapy and conventional chemotherapy. 
The first critical factor for chemotherapy is the limited delivery of 
chemotherapeutic agents through blood brain barrier (BBB). The drug toxicity 
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towards normal tissues and high resistance of glioblastomas to current chemotherapy 
are the other difficulties (Reardon et al, 2006). There are also side-effects for 
chemotherapy, including nausea, headache, fatigue and convulsion. However, 
survival rates of anaplastic astrocytomas after surgical resection and radiation is 60% 
in 1 year, 20% in 3 years and 16% in 5 years as compared with 80% in 1 year, 39% 
in 3 years and 18% in 5 years with chemotherapy as an adjuvant therapy. Therefore, 
it is important to find a novel chemotherapeutic agent that can pass through BBB and 
eliminate the brain tumors without causing severe side-effects (Lemke, 2004). 
Ideal features of attractive chemotherapeutics for brain tumors are those 
that can readily across BBB, achieving the cerebrospinal fluid concentration to 
approximately 40% of plasma, nearly 100% bio-available after oral administration, 
not requiring hepatic metabolism for activation, exhibiting the pharmacokinetics with 
little inter-subject or intra-subject variation and with generally mild and predictable 
side-effects (Reardon et al., 2006). Although the use of chemotherapy is limited by 
drug delivery and toxicity, but the development of new drug delivery techniques such 
as convection-enhanced delivery, which delivers therapeutic molecules at an 
effective concentration directly to the brain, may reduce systemic exposure to 
cytotoxic drugs (Butowski et al, 2006). 
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For high grade astrocytomas, the standard treatment consists of resection 
surgery followed by radiotherapy and chemotherapy. However, treatment options 
would be changed for patients with recurrent malignant astrocytomas such as repeat 
resection, photodynamic radiotherapy, adjuvant chemotherapy, targeted therapy, etc. 
Repeat radiation on brain may result in necrosis of healthy brain tissues, and 
therefore it is usually not advisable to perform re-radiation for patients with recurrent 
tumors (Butowski et al., 2006). 
4.1.5. Glutathione Levels in Brain Normal and Cancer Cells 
GSH levels were about 195 |Lig/g in glioblastomas, 322 j^g/g in 
astrocytomas grades II and III and 444 |ag/g in normal brain tissues from clinical 
samples (Kudo et al., 1990). It was also shown that neurons and SH-SY5Y 
neuroblastoma had basal GSH contents of 27.1 and 14.5 nmol/mg protein (Sebastia 
et al., 2003). Therefore, it is well worth investigating whether baicalein induces 
cancer cell death by GSH depletion and whether the differential drug susceptibilities 
are correlated to the GSH levels of the cell lines investigated. 
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4.2. Materials and Methods 
4.2.1. Instruments 
Polarion-automated fluorescence polarization microplate reader (TECAN). 
4.2.2. Chemicals 
Fluorescent dye CMAC was obtained from Molecular Probes (Eugene, USA). 
4.2.3. Buffers 
Assay buffer 
0.3 mM NADPH in 143 mM sodium phosphate and 6.3 mM Na4-EDTA, the 
solution pH was adjusted to 7.5 
Phosphate-buffered saline (PBS) 
See Section 3.2.3 
4.2.4. Determination of Cell Proliferation by MTT Assay 
See Section 3.2.6 
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4.2.5. Determination of Intracellular Glutathione Depletion by Fluorescent Dye 
CMAC 
Five thousand cells per well for U87-MG, U138-MG and HepG2 were 
seeded in a 96-well plate and allowed to grow overnight (24 h) to achieve about 80% 
confluence and 1000 cells per well for NHA were seeded in a 96-well plate and 
allowed to grow for 48 h to achieve about 80% confluence. The cells were treated 
with control vehicle (DMSO) or different concentrations of baicalein for different 
periods of time. After treatment, the media were removed and the cells were washed 
twice with PBS. The basal fluorescence signal was determined by 
Polarion-automated fluorescence polarization microplate reader (TECAN) with 
excitation/emission wavelengths: 360 nm/465 nm. CMAC (final concentration 5 fiM) 
in pre-warmed serum-free medium was added to each well and incubated in dark at 
37°C for 30 min in a humidified atmosphere of 5% CO2 and 95% air. The media 
were removed and the cells were washed with PBS for twice. Complete culture 
media were added and incubated in dark at TTC for fbrther 30 min. The media were 
removed and the cells were washed with PBS for twice. The cells were fixed by 
3.70/0 formaldehyde in dark at room temperature for 15 min and the cells were 
washed with PBS for twice. The fluorescence signals were determined by 
fluorescence microplate reader with excitation/emission: 360 nm/465 nm. 
71 
Chapter 4 Glutathione-Depleting Effects of Baicalein on Cell Viabilities on Different Cell 
Lines 
(fluorescent signal test sample- fluorescent signal background) 
% of control = " " " “ ~"""； “ ~ ； ：""" X 100% 
(fluorescent signal control- fluorescent signal background) 
By definition, the intracellular GSH level of the control cells 
(DMSO-treated) was defined as 100%. 
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4.2.6. Determination of Cellular Reduced Glutathione Levels by 
DTNB-Coupled Glutathione Reductase Recycling Assay 
Cellular reduced glutathione level is determined by enzymatic kinetic 
spectroscopy in the presence of glutathione reductase and p-nicotinamide adenine 
dinucleotide phosphate, with the addition of colorimetric substrate DTNB. This assay 
was used to determine the basal levels of reduced glutathione in different normal and 
cancer cell lines investigated. All data were normalized by mg of protein of total cell 
ly sates. 
Cells per well were seeded into a 6-well plate (2 x 10. cells/well) and allow 
to grow overnight (24 h) to achieve about 90% confluence. The media were removed 
and the cells were washed with ice-cold PBS with 0.05 mM EDTA for twice. One ml 
of 10 mM HCl was added to each well and the plate was then incubated on ice for at 
least 10 min. The cell suspensions were collected by scrapping and transferred to 
new eppendorf tubes. The cells were sonicated on ice for 10 s at 30% power by a 
Sonicator Cell Disrupter. The cell lysates were centrifbged at 10,000 g at 4°C for 5 
min. The supematants of cell lysates were immediately added with ice-cold SSA 
(final concentration 3.33%) and incubated on ice for 10 min. The cell pellets were 
added with NaOH (final concentration 0.5 mM) and the protein concentrations were 
determined by Lowry assay with BSA as standard. The SSA-treated samples were 
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centrifUged at 10,000 g at 4°C for 5 min and the supematants were then subjected to 
GSH level determination by DTNB-coupled GR recycling method suggested by 
Anderson (1996) with some modifications. The amounts of GSH were calculated 
based on GSH calibration curve. In brief, 150 jiil assay buffer (0.3 mM NADPH in 
143 mM sodium phosphate and 6.3 mM Na4-EDTA, pH 7.5) was added with 20 |il 
samples or GSH standard in a 96-well plate. The reaction was started by addition of 
GR (0.048 unit/ml) and 25 |LI1 DTNB (6 mM in 143 mM sodium phosphate and 6.3 
mM Na4-EDTA, pH 7.5, final concentration 0.75 mM) was added. The rate of 
) 
reduction of DTNB (or the formation of TNB '), which was proportional to the 
amount of glutathione in the samples, was continuously determined by the 
absorbance at 412 run (A 412 nm) for 30 min. Cellular GSH levels were expressed as 
nmol per mg protein. 
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4.3. Results 
4.3.1. Effects of Baicalein on Intracellular Glutathione Levels and Cell 
Proliferation for Different Cell Lines 
The data presented in Figure 4-1 showed that baicalein in concentrations 
ranging from 50-150 |LIM depleted intracellular glutathione in U87-MG in a 
dose-dependent manner in 2-day treatment. At the concentrations of 100 and 150 |LIM 
baicalein, GSH levels were reduced to around 15% and 0%, respectively. 
There were no observable effects of DMSO on GSH levels and cell 
proliferation of U87-MG (Figure 4-2a), U138-MG (Figure 4-3a), HepG2 (Figure 
4-4a) and NHA (Figure 4-5a) throughout 3-day treatment. 
Baicalein depleted GSH and inhibited cell proliferation in a time-dependent 
manner in U87-MG (Figure 4-2b). GSH levels started to decrease to 70%, 50% and 
10% at 30-, 48- and 72-h baicalein treatment (50 |nM), respectively. It was observed 
that baicalein-induced GSH depletion was followed by cell death in U87-MG. 
However, baicalein treatment (50 \M) did not significantly affect GSH 
levels and cell proliferation of U138-MG (Figure 4-3b)，HepG2 (Figure 4-4b) and 
NHA (Figure 4-5b) within 3-day treatment. 
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Figure 4-1. Effect of Baicalein on Intracellular Glutathione Level of U87-MG. 
U87-MG cells were treated with control vehicle (DMSO), or indicated 
concentrations of baicalein for 2 days. After treatment, the intracellular GSH levels 
were determined by CMAC as described in Methods (Section 4.2.5). 
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(a) Effect of DMSO on GSH level and proliferation of U87-MG cells 
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Figure 4-2. Effects of DMSO and Baicalein (50 |iM) on Glutathione level and Cell 
Proliferation of U87-MG within 3-day Treatment. U87-MG cells were treated with (a) 
control vehicle (DMSO) or (b) indicated concentrations of baicalein for 
corresponding period of time. After treatment, the intracellular GSH levels were 
determined by CMAC as described in Methods (Section 4.2.5) while the cell 
proliferation was determined by MTT as described in Methods (Section 3.2.6) 
simultaneously. 
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(a) Effect of DMSO on GSH level and proliferation of U138-MG cells 
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(b) Effect of 50 juM Baicalein on GSH level and proliferation of U138-MG cells 
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Figure 4-3. Effects of DMSO and Baicalein (50 [iM) on Glutathione Level and Cell 
Proliferation of U138-MG within 3-day Treatment. U138-MG cells were treated with 
(a) control vehicle (DMSO) or (b) indicated concentrations of baicalein for 
corresponding period of time. After treatment, the intracellular GSH levels were 
determined by CMAC as described in Methods (Section 4.2.5) while the cell 
proliferation was determined by MTT as described in Methods (Section 3.2.6) 
simultaneously. 
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Figure 4 -4 . Effects of D M S O and Baicalein (50 |LIM) on Glutathione Level and Cell 
Proliferation of HepG2 within 3-day Treatment. HepG2 cells were treated with (a) 
control vehicle (DMSO) or (b) indicated concentrations of baicalein for 
corresponding period of time. After treatment, the intracellular GSH levels were 
determined by CMAC as described in Methods (Section 4.2.5) while the cell 
proliferation was determined by MTT as described in Methods (Section 3.2.6) 
simultaneously. 
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Figure 4-5. Effects of DMSO and Baicalein (50 f^M) on Glutathione Level and Cell 
Proliferation of NHA within 3-day Treatment. NHA cells were treated with (a) 
control vehicle (DMSO) or (b) indicated concentrations of baicalein for 
corresponding period of time. After treatment, the intracellular GSH levels were 
determined by CMAC as described in Methods (Section 4.2.5) while the cell 
proliferation was determined by MTT as described in Methods (Section 3.2.6) 
simultaneously. 
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4.3.2. Basal Intracellular Glutathione in Different Cell Lines 
The basal glutathione levels for U87-MG, U138-MG and NHA cells were 
found to be 13.30 土 0.97, 15.86 土 2.81 and 42.3 士 0.1 nmol/mg protein, respectively 
(Figure 4-6). The glutathione level in the normal human astrocytes (NHA) was about 
3-fold higher than in the brain cancer cells. 
The basal glutathione levels for HepG2, Hep3B, BEL7404 and L02 cells 
were found to be 6.05 土 0.64, 9.08 士 0.22，5.01 士 0.56 and 6.52 士 0.72 nmol/mg 
protein, respectively (Figure 4-7). The basal GSH level in L02 was found to be 
significantly higher than BEL7404 but lower than Hep3B, while there were no 
significant differences between HepG2 and L02 cells. 
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Figure 4-6. Determination of Basal GSH Levels in Different Human Brain Cell Lines 
by DTNB-Coupled Glutathione Reductase Recycling Assay. The basal GSH levels of 
U87-MG, U138-MG and NHA were determined the day after seeding without any 
treatments as described in Methods (Section 4.2.6). Results were expressed as the 
mean values (n=3) and error bars represent standard deviations. Statistical analysis 
were performed with one-way ANOVA followed by Tukey's Multiple Comparison 
Test. * P-value < 0.05, ** 尸-value < 0.01, *** 户-value < 0.001 as compared with the 
normal human astrocytes (NHA). 
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Figure 4-7. Determination of Basal GSH Levels in Different Human Liver Cell Lines 
by DTNB-Coupled Glutathione Reductase Recycling Assay. The basal GSH levels of 
HepG2, Hep3B, BEL7404 and L02 were determined the day after seeding without 
any treatments as described in Methods (Section 4.2.6). Results were expressed as 
the mean values (n=3) and error bars represent standard deviations. Statistical 
analysis were performed with one-way ANOVA followed by Tukey's Multiple 
Comparison Test. * 户-value < 0.05, ** 户-value < 0.01, *** 户-value < 0.001 as 
compared with the human normal liver cell (L02). 
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4.4. Discussion 
4.4.1. Intracellular Glutathione Depletion and Cell Death Induction Effects of 
Baicalein on Different Cell Lines 
Since the ED50 for U87-MG is 50 pM for 2-day treatment, 50 |jM was used 
for the subsequent experiments for time-dependent GSH depletion and cell death 
induction effects. At this concentration, the cell proliferation of normal human 
astrocytes would not be affected. 
Baicalein depleted intracellular GSH in U87-MG in a dose- (Figure 4-1) 
and time-dependent manner (Figure 4-2b). This result was consistent to glutathione 
and thiol depletion assay in Chapter 2. The baicalein-induced GSH depletion started 
to be observed at 30 h and followed by cell death at 48 h. In contrast to other cell 
lines, GSH depletion occurred prior to baicalein-induced cell death in U87-MG This 
suggested that baicalein may deplete GSH and resulted in cell death in U87-MG. 
This comes to the question whether the GSH levels of different cell lines 
could correlate to their drug susceptibilities and baicalein could induce cancer cell 
death by apoptosis. 
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4.4.2. Relationship between Basal Glutathione Levels and Drug Susceptibilities 
Baicalein preferentially induced cell death in brain cancer cells but not in 
their normal counterparts, suggesting one of the following possibilities: normal cells 
may be more adaptive to GSH depletion, baicalein may not deplete GSH in normal 
cells or extent of GSH depletion and cell death are differentially modulated in normal 
cells. 
It was obvious that GSH level in NHA was about 3-fold higher than that in 
U87-MG and U138-MG, which was consistent to the study from clinical samples that 
GSH levels in normal brain tissues were higher than that in tumors (Kudo et al., 
1990). The GSH levels increased from U87-MG < U138-MG « NHA. This may 
correlate to their susceptibilities towards baicalein treatment. In the comparison to 
the MTT results, U87-MG was the most sensitive to baicalein treatment, followed by 
U138-MG while baicalein did not significantly affect the cell proliferation of NHA. 
It was also demonstrated that the differential sensitivities of human maglinant 
astrocytoma cell lines (UWRl, UWR2 and UWR3) towards 
1,3-bis(2-chloroethyl)-1 -nitrosourea) (BCNU) were highly correlated to their 
intracellular GSH levels and GST activites. The most resistant cell line UWRl was 
found to have the highest GSH level and GST activity (Li-Osman et al,, 1990). This 
suggested that GSH level may be one of the factors contributing to the differential 
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susceptibilities towards biacalein treatment among brain normal and cancer cells. 
On the contrary, there was no obvious and direct relationship between GSH 
levels and drug susceptibilities in normal and cancer liver cells. Some studies showed 
that when hepatoma developed, GSH levels were found to be significantly decreased 
with subsequent decreased detoxification abilities (Locigno and Castronovo, 2001; 
Lin et al, 2005). This was also demonstrated in our study that normal and cancer 
liver cells had lower GSH levels than U87-MG, however, they were less sensitive to 
baicalein treatment. One of the possible reasons is that although liver cells have 
lower basal GSH levels than U87-MQ they may have a higher antioxidant defense 
activity such that they could maintain steady redox state throughout 
baicalein-treatment (shown in Figure 4-4). This was consistent to the results from 
another study that baicalin treatment did not affect hepatic GSH levels in vivo (Jang 
et a/., 2003). 
In addition to differential GSH levels, there might be other possible 
underlying mechanisms for different susceptibilities towards baicalein. It was 
reported that pro-apoptotic tumor suppressor p53 status of different astrocytoma cell 
lines are different. For instance, U87-MG cells possess a wild-type p53, while 
U138-MG and U373-MG cells (Lis et al., 2004) possess a mutated p53. H2O2 is able 
to induce apoptosis in U87-MG (wild-type p53) in a dose-dependent manner. 
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However, U138-MG and U373-MG (mutated p53) cells are comparatively resistant 
to H202-induced cell death (Datta et al., 2002). In this study, U87-MG was found to 
be more susceptible than U13 8-MG to baicalein treatment. 
Human hepatoma cell lines HepG2 and Hep3B used in this study also 
possess different p53 status: HepG2 (wild-type p53) and Hep3B (mutated p53) (Qiu 
et al., 2004; Lipinski et al., 2001; Lee et al., 2000; Mohr et al., 2000). A study 
showed that Hep3B had a 7-kB deletion after exon of p53 (Lin et al., 1996). 
Coincidently, Hep3B was found to be comparatively more resistant than HepG2 
towards baicalein treatment. 
It was suggested that cancer cells with a wild-type p53 were more sensitive 
to chemotherapeutic agents and radiation than cells without functional p53. The 
sensitivity of wild-type p53 cells was proposed to be attributable to their tendencies 
to undergo p53-mediated apoptosis after therapy (Xie et al., 1999). This may explain 
the higher susceptibility of cancer cells with wild-type p53 (U87-MG) than 
corresponding cancer cells without functional p53 (U138-MG) towards baicalein 
treatment. 
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Chapter 5 Effects of Baicalein on Apoptosis and 
Caspase Pathways 
5. Baicalein Induced Apoptosis and Activated Caspase Pathways 
5.1. Introduction-Modes of Cell Death 
Cell death is an essential strategy to control the dynamic balance in 
mammals, e.g. organ and tissue development, immune response, etc. There are two 
types of cell death: apoptosis and necrosis. 
5.1.1. Necrosis 
Necrosis is an accidental passive process resulting in an early disruption of 
the cell membrane and in the progressive breakdown of ordered cell structures. It 
involves mitochondrial swelling due to the damage of the mitochondrial outer 
membrane, nuclear flocculation and uncontrolled cell lysis. Necrosis always results 
in inflammation and triggers immune responses (Hall, 1999). 
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5.1.2. Apoptosis 
Apoptosis, which is also called programmed cell death, involves the 
activation of an energy-requiring intracellular machinery. It is a process with definite 
morphological characteristics such as cell membrane blebbing, cell shrinkage, 
nuclear chromatin condensation and DNA fragmentation (Vermeulen et al., 2005). 
On the contrary to necrosis, apoptosis maintains mitochondrial membrane 
intact but the mitochondrial membrane potential (MMP) is lost and changes 
permeability transition. Apoptosis is a tightly regulated process involving several 
checkpoints before a point of no return is reached and irreversible cellular 
degradation begins. There are some important events to control final commitment to 
undergo apoptosis before any morphological changes. Three distinct phases in 
apoptosis are (Hall, 1999): 
Initiation 
It involves the detection of an apoptotic stimulus which is potentially 
reversible and will not trigger apoptosis if the downstream effectors are not activated. 
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Commitment 
It involves a limited number of pathways, e.g. the collapse of mitochondrial 
membrane potential, activation of caspase pathways, etc. 
Degradation 
It involves a range of cellular processes including the activation of 
endonucleases to produce intemucleosomal DNA fragments. The patterns of DNA 
fragmentations appear to differ among cells. 
Caspases are important for the proteolytic cleavage of cellular proteins 
resulting in DNA fragmentation. Caspases are synthesized as inactive pro-enzymes, 
which are activated by autoproteolytic cleavage or cleavage by other caspases. 7 out 
of 14 caspases mediate apoptosis. During apoptosis, caspases with long pro-domains 
function as upstream signal transducers (initiator caspases) and proteolytically 
activate downstream caspases (effector caspases). There are two pathways to activate 
caspases: first, binding of a death ligand to its transmembrane death receptor, 
followed by recruitment and activation of caspases in death-inducing signaling 
complex; second, mitochondria release caspase-activating proteins into the cytosol 
and form apoptosome where caspases bind and become activated (Vermeulen et al， 
2005). 
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The initiator caspase-8 contains a death effector domain (DED) in their 
pro-domain to interact with adaptor proteins. A caspase recruitment domain (CARD) 
is found in caspase-9 and is important for binding of adaptor proteins and activation 
of effector caspases such as caspase-3. Subsequently, caspase activation results in 
intemucleosomal DNA cleavage and generation of oligonucleosomal DNA 
fragments. 
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5,2. Materials and Methods 
5.2.1. Chemicals 
Fluorescent dyes JC-1 and PI were purchased from Molecular Probes 
(Eugene, USA). Annexin V-GFP was a generous gift from Professor S.K. Kong, the 
Department of Biochemistry, The Chinese University of Hong Kong. In situ Cell 
Death Detection Kit was purchased from Roche Diagnostics (Mannheim, Germany). 
APO LOGIX carboxyfluoroscein caspase detection kits were purchased from Cell 
Technology Inc. (Minneapolis, MN, USA). 
5.2.2. Buffer 
Annexin V binding buffer 
10 mM HEPES, 150 mM NaCl，5 mM KCl, 1 mM MgCh, 2 mM CaCla, 
solution pH was adjusted to 7.4 with sodium hydroxide 
Lysis buffer 
3% NP-40，20 mM EDTA, 50 mM Tris, the solution pH was adjusted to 7.5 
Tris-EDTA buffer (TE buffer) 
10 mM Tris, pH 7.5, 0.1 mM EDTA, 100 \iglm\ RNAseA 
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5.2.3. Determination of Changes of Mitochondrial Membrane Potential by 
JC-1 
The changes in mitochondrial membrane potential (MMP) were determined 
by uptake of fluorescent dye JC-1. This dye is cell-permeable, which binds to the 
mitochondria depending on the inner MMP. The uptake of JC-1 is directly related to 
MMP across the mitochondrial inner membrane. JC-1 exists as a green-fluorescent 
monomer at low membrane potential. However, at high potential, JC-1 forms 
red-fluorescent 'J-aggregates'. JC-1 is widely used for detecting mitochondrial 
membrane depolarization in apoptotic cells. 
Cells were seeded in a 6-well plate (2 x 10'^  cells/well) and allowed to grow 
overnight (24 h) to obtain about 90% confluence. The cells were treated with control 
vehicle (DMSO) or baicalein with different concentrations for different periods of 
time. About 1 x 10^ cells were collected by trypsinization and the cell pellets were 
washed with PBS once and resupsended in PBS. The cell suspensions were incubated 
with JC-1 (final concentration 10 |LIM) in PBS in dark at 37�C for 30 min. The 
signals for green (FLl) and orange fluorescence (FL3) were acquired in a contour. 
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5.2.4. Determination of Apoptosis by Annexin V-Propidium Iodide Staining 
One of the early features of apoptosis is transposition of phosphatidylserine 
residues from the inner to the outer leaflet of the plasma membrane, which can be 
detected by the binding of annexin V. The flipping is important for promotion of 
phagocytosis by surrounding macrophages (Hall，1999). 
U87-MG cells were plated at a density of 2 x lO* cells per well (5 ml/well) 
into a 6-well plate and allowed to grow overnight (24 h) to achieve 90% confluence. 
The cells were treated with control vehicle (DMSO) or baicalein with different 
concentrations for different periods of time. After treatment, about 1 x 10^ cells were 
collected by trypsinization and the cell pellets were washed with PBS once and 
resupsended in 500 |al annexin V binding buffer containing 494 [i\ annexin V binding 
buffer, 5 |il annexin V-GFP and 1 j^ l propidium iodide (2 mg/ml). The cell 
suspension was stained at room temperature for 15 min. The signals for green (FLl 
channel) and orange fluorescence (FL3 channel) were acquired in a dot-plot. 
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5.2.5. Determination of Cell Cycle Arrest by Propidium Iodide Staining 
Cells were seeded in a 6-well plate (2 x lO"^  cells/well) and allowed to grow 
overnight (24 h) to achieve about 90% confluence. The cells were treated with 
control vehicle (DMSO) or baicalein with different concentrations for different 
periods of time. After treatment, about 1 x 10^ cells were collected by trypsinization 
and the cell pellets were washed with PBS once and resupsended in 100 \x\ PBS. 1 ml 
of 70% ethanol was added and the cells were then completely resuspended. The cell 
suspensions were stored at 4°C overnight. The cells were centrifiiged and washed 
with 1 ml PBS once. The cell pellets were resuspended with 1 ml PBS containing 
RNase A (8 jtig/ml) and propidium iodide (40 i^g/ml). The cell suspensions were then 
incubated in dark at 37°C for 15 min. The signal for orange fluorescence (FL3) was 
acquired in a histogram. The DNA histograms were further analyzed by ModFit 
software (Becton Dickinson, Meylan Cedex, France) to estimate the percentage of 
each phase in the cell cycle. 
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5.2.6. Determination of Caspase-3, -8 and -9 Activities by Fluorescent-Labeled 
Peptides 
Caspase-3, -8 and -9 activities were determined by APO LOGIX 
carboxyfluoroscein caspase detection kits (Cell Technology, Inc., Minneapolis, MN) 
according to the manufacturer's instructions. The kits contain FITC-labeled cell 
permeable peptides FAM-DEVD-FMK, FAM-LETD-FMK and FAM-LEHD-FMK, 
which preferentially and irreversibly bind to and inhibit active caspase-3，-8 and -9, 
respectively. After incubation with caspase detection reagents, cells were analyzed by 
flow cytometry. 
Cells were seeded in a 6-well plate (2 x cells/well) and allowed to grow 
overnight (24 h) to obtain about 90% confluence. The cells were treated with control 
vehicle (DMSO) or baicalein with different concentrations for different periods of 
time. After drug treatment, 10 3 OX working FAM-peptide-FMK solution was 
added to 440 |LI1 serum-free medium and directly added to each well. The cells were 
incubated at 37°C, 5% CO2 for 1 h in dark. About 1 x 10^ cells were washed with 1 
ml IX working dilution washing buffer once. The cells were collected by 
trypsinization and the cell pellets were washed with 1 ml IX working dilution 
washing buffer twice and resupsended in 500 i^l working dilution washing buffer. 
The signal for green fluorescence (FLl) was acquired in a histogram. 
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5.2.7. Determination of DNA Fragmentation 
Cells were seeded in a 100 mm dish (3 x cells/dish) and allowed to 
grow overnight (24 h) to achieve about 90% confluence. The cells were treated with 
control vehicle (DMSO) or baicalein with different concentrations for 48 h. About 1 
X 10^  cells were collected by trypsinization and the cell pellets were washed with 
PBS once and resupsended in 1 ml PBS with 50 mM EDTA. The cell suspensions 
were centrifuged at 1,500 g for 5 min. The cell pellets were then resuspended in 200 
|Lil lysis buffer (3% NP-40, 20 mM EDTA, 50 mM Tris pH 7.5) and 50 |LI1 of 5% SDS 
was added to the supernatant and mixed well by several inversion. The samples were 
incubated with 1.5 mg/ml proteinase K at 45°C for 2 h. The supernatant was further 
incubated with 0.4 mg/ml RNAse A at 37°C for 2 h. DNA was isolated by adding 
500 |il phenol/chloroform reagent with vigorous vortexing. The samples were then 
centrifuged at 4°C at 13,000 g for 5 min. The upper aqueous layers were transferred 
to new eppendorf tubes and isolation step by phenol/chloroform reagent was repeated 
once. DNA was precipitated with one-tenth volume of sodium acetate and 2.5 
volume of 100% ethanol (pre-cold at -20°C) and well mixed. The samples were left 
overnight at -20°C. The samples were centrifuged at 4°C at 15,000 g for 30 min. The 
pellets were washed with 1 ml 100% ethanol (pre-cold at -20°C) and centrifuged at 
4 � C at 15,000 g for 5 min. The pellets were vacuum dried and DNA pellets were 
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incubated in 20 |al TE buffer (10 mM Tris, pH 7.5, 0.1 mM EDTA, 100 |ig/ml 
RNAse A) at 37°C for 1 h. The DNA concentrations for different samples were 
determined by the absorbance at 260 nm (A 260 nm). About 10 jag DNA per each 
sample was loaded to 1.5% agarose gel and ran at 80 V for 1 h. The DNA fragments 
were stained by ethidium bromide (EtBr). The gel was visualized by UV light and 
the images were captured by Gel Documentation System (Alpha Innotech, Bio-Rad). 
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5.2.8. Terminal Deoxynucleotidyl Transferase Mediated dUTP End Labeling 
(TUNEL) Assay 
The DNA fragmentation induced during apoptosis can also be detected by 
the TUNEL technique (In Situ Death Detection Kit, Fluorescein, Roche Diagnostics, 
Mannheim, Germany). This assay uses terminal deoxynucleotidyl transferase (TdT) 
to catalyze the binding of FITC-conjugated dUTP to the end of DNA strand breaks. 
4 
Cells were seeded in a 6-well plate (2x10 cells/well) and allowed to grow 
overnight (24 h) to obtain about 90% confluence. The cells were treated with control 
vehicle (DMSO) or baicalein with different concentrations for different periods of 
time. After treatment, the cells were washed with PBS twice. About 1 x 10^  cells 
were collected by trypsinization and the cell pellets were washed with PBS once and 
resupsended in 1 ml PBS. 1 ml freshly prepared fixation solution (4% 
paraformaldehyde in PBS, pH 7.4) was added to the cell suspension to final 2% 
paraformaldehyde and incubated at room temperature for 60 min with continuous 
shaking. The cell suspensions were centrifuged at 1,500 g for 5 min. The cell pellets 
were washed with PBS once and centrifuged at 1,500 g for 5 min. The cell pellets 
were resuspended and incubated in 1 ml freshly prepared permeabilization solution 
(0.1% Triton X-100 in 0.1% sodium citrate) on ice for 2 min. The cell suspensions 
were washed with PBS for once and added with TUNEL reaction mixture 99 
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(fluorescent label dye and TdT enzymes). The cell suspensions were incubated at 
37°C for 60 min in dark. The samples were washed with PBS once and resuspended 
in 1 ml PBS. The signal for green fluorescence (FLl) was acquired in a histogram by 
flow cytometry. 
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5.2.9. Flow Cytometry 
All the subsequent flow cytometric experiments were performed as follows: 
For each sample, the fluorescent signals of total 10,000 cells (events) were collected 
and detected by FACSort flow cytometer (Becton Dickinson, Meylan Cedex, France). 
Forward light scatter (FSC)，which can be correlated to the cell size and the 
right-angle light scatter (SSC), which can be correlated to the granularity of cells, 
were used to establish gates and exclude cellular debris for the flow cytometric 
analysis. The fluorescence dyes were excited by a 488 nm Argon-ion excitation laser 
and the signals were detected by different band pass filters depending on the 
emission spectrum of the corresponding fluorescent dyes. 
For the flow cytometric analysis，the cell cycles were analyzed using the 
computer software Cell Quest (Becton Dickinson, Meylan Cedex, France) while 
other histograms and dot-plots were analyzed by the WinMDI2.8 software (Scripps 
Institute, La Jolla, CA, USA). 
101 
r 
Chapter 5 Effects of Baicalein on Apoptosis and Caspase Pathways 
5.3. Results 
5.3.1. Effects of Baicalein on Mitochondrial Membrane Potential by JC-1 
Staining 
Disruption of mitochondrial membrane potential (MMP) is an early event in 
apoptosis. Figure 5-1 showed that baicalein did not significantly affect MMP at 6-h 
treatment. High baicalein concentration (200 |uM) could only slightly affect MMP at 
8-h treatment. 
Baicalein induced changes in MMP in a dose-dependent manner at 16，24-
and 30-h treatments, except at the highest baicalein concentration (200 |LIM) for 24-
and 30-h treatments. 
At 24- and 30-h treatments, there were observable changes in MMP that the 
extent of orange fluorescent signal became higher with baicalein concentration, 
which could not be quantified by the percentage within the marked regions. 
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Figure 5-1. Effect of Baicalein on Mitochondrial Membrane Potential. U87-MG cells 
were treated with (a) control vehicle (DMSO) or (b) indicated concentrations of 
baicalein for corresponding period of time. After treatment, MMP was determined by 
JC-1 as described in Methods (Section 5.2.3). 
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5.3.2. Effects of Baicalein on Apoptosis and Necrosis by Annexin V-Propidium 
Iodide Staining 
When cells die, the integrity of cell membranes is lost. This allows PI to 
penetrate and label DNA. Thus, PI can stain both apoptotic and late necrotic cells. In 
contrast, annexin V is specific for staining apoptotic cells. During early apoptotic 
stage, phosphatidylserine, which is a phospholipid usually located on the inner 
surface of cell membrane, translocates to the outer cell membrane because of the loss 
of membrane phospholipid symmetry and annexin V preferentially binds to the 
negatively charged phosphatidylserine. This is a unique process for apoptosis, but not 
necrosis. 
There was no induction of apoptosis or necrosis at 8-h and 16-h treatments 
of baicalein on U87-MG (data not shown). Figure 5-2 showed that baicalein 
significantly induced apoptosis in a dose- and time-dependent manner for 24-, 30-
and 48-h treatments. Baicalein also induced necrosis in the same treatments, however, 
there was no direct relationship between the concentration of baicalein and the 
number of necrotic cells. Therefore, induction of apoptosis but not necrosis mainly 
attributed to baicalein-induced cell death. 
104 
Chapter 5 Effects of Baicalein on Apoptosis and Caspase Pathways 
In the comparison of MTT assay, 50 |LIM baicalein was found to inhibit 50% 
U87-MG cell proliferation at 48-h by MTT assay while only around 23% dead cells 
was detected by annexin V-propidium iodide assay for the same baicalein 
concentration. It was because the detection of phosphatidylserine exposure by 
annexin V is used for staining cells undergoing early apoptosis. 
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Figure 5-2. Effect of Baicalein on Apoptosis and Necrosis by Annexin V-Propidium 
Iodide Staining. U87-MG cells were treated with (a) control vehicle (DMSO) or (b) 
indicated concentrations of baicalein for corresponding period of time. After 
treatment, apoptosis and necrosis were determined by AV-PI as described in Methods 
(Section 5.2.4). 
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Figure 5-3. Prism Analysis for Apoptosis by Annexin V-Propidium Iodide Staining. 
Results were expressed as the mean values (n=3) and error bars represented standard 
deviations. Statistical analysis were performed with one-way ANOVA followed by 
Tukey's Multiple Comparison Test. * 尸-value < 0.05，** 户-value < 0.01，*** P-value 
< 0.001 as compared with the control in the same treatment group. 
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5.3.3. Effects of Baicalein on Cell Cycle Arrest by Propidium Iodide Staining 
It was observed that baicalein induced the DNA accumulation in GQGI 
phase in a dose-dependent manner from 0-100 \xM baicalein treatments. At 16-h 
treatment, baicalein caused the disappearance of G2M phase. At 24-h treatment, 
baicalein induced cell cycle arrest at GQGI peak in a dose-dependent manner and an 
increase of the cell population in sub-Gi phase, showing that baicalein-treated 
U87-MG cells underwent apoptosis. 
Since there were no dramatic changes in the cell cycle of baicalein-treated 
U87-MG cells, the detailed apoptotic pathway, instead of the protein regulator of cell 
cycle check point was further investigated. 
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Figure 5-4. Effect of Baicalein on Cell Cycle of U87-MG Cells. U87-MG cells were 
treated with control vehicle (DMSO) or indicated concentrations of baicalein for 
corresponding period of time. After treatment, DNA was stained by PI as described 
in Methods (Section 5.2.5). 
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5.3.4. Effects of Baicalein on Caspase-3, -8 and -9 Activities 
Since apoptosis may be caspase-dependent or -independent, the activation 
of initiator caspase-8 and -9 and executor caspase-3 were examined. 
Caspase-3 is the final executor in the apoptotic pathway and relies on the 
activation of initiator caspases including caspase-8 and -9. 
Our results showed baicalein induced marked caspase-8, -9 and -3 
activations in U87-MG cells in a dose-dependent manner. Baicalein induced 
caspase-8, -9 and -3 activations in a time-dependent manner for 24- and 30-h 
treatment. However, the activities of caspase-8 and caspase-9 dramatically declined 
at 48-h treatment while there was a slight drop in caspase-3 acitivation compared 
with 30-h treatment. This may be because cells undergo the final stage of apoptosis 
at such a long treatment time (i.e. 48-h) and thus caspase-3 activity still remained 
high. 
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Figure 5-5. Effects of Baicalein on Caspase-8 Activation. U87-MG cells were treated 
with control vehicle (DMSO) or indicated concentrations of baicalein for 
corresponding period of time. After treatment, FLl green fluorescence signals were 
measured by flow cytometry as described in Methods (Section 5.2.8). 
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Figure 5-6. Effect of Baicalein on Caspase-9 Activation. U87-MG cells were treated 
with control vehicle (DMSO) or indicated concentrations of baicalein for 
corresponding period of time. After treatment, FLl green fluorescence signals were 
measured by flow cytometry as described in Methods (Section 5.2.8). 
112 
Chapter 5 Effects of Baicalein on Apoptosis and Caspase Pathways 
24-h 30-h 48-h 
DMSO DMSO DMSO 
R 5 n 
.JMjk^. .Jmk.. . . 
10' 10* ？0 ‘ 10* 10' 10' 10' lb* 10* 10' 10* 10' 10* 
50 [iM B 50 ^iMB 50 ^M B 
10- '' 1 ~；^ ？0' �10� io' io' 10' To. 
100 [ M B lOOjiiMB 100 ^M B 
s ？ s 
I ••二喻谓 I ‘ ?�• � i l� I • l o " ^ ™ ® ? * ' ^ ?�• 
150|aMB 150 ^MB 150 |iM B 
一 急 膨 - 一 I - I 職 
1 ^ 1 ^ i 
. K 7 M j y l 
Figure 5-7. Effects of Baicalein on Caspase-3 Activation. U87-MG cells were treated 
with control vehicle (DMSO) or indicated concentrations of baicalein for 
corresponding period of time. After treatment, FLl green fluorescence signals were 
measured by flow cytometry as described in Methods (Section 5.2.8). 
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Figure 5-8. Prism Analysis for Caspase-3，-8 and -9 Activation Assays. Baicalein 
treated U87-MG for (a) 24-h, (b) 30-h and (c) 48-h. Results were expressed as the 
mean values (n=3) and error bars represented standard deviations. Statistical analysis 
were performed with one-way ANOVA followed by Tukey's Multiple Comparison 
Test. * P-value < 0.05，** P-value < 0.01, *** 尸-value < 0.001 as compared with the 
control in the same treatment group. 
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5.3.5. Effects of Baicalein on DNA Fragmentation 
The appearance of the nucleosomal DNA ladder in agarose gels is an 
important hallmark of late apoptotic feature. However, it was also reported that no 
intemuclesomal DNA cleavage was detected in some cell lines. In the absence of 
detectable nucleososomal DNA fragmentation, high molecular weight fragments 
(HMW) ranging in size between 50 and 300 kb might also provide another 
characteristic feature of apoptosis. Figure 5-9 showed that baicalein induced DNA 
fragmentation at 48-h while no DNA fragments were observed at 24-h (data not 
shown). Large DNA fragments (around 3,500 bp) were observed for baicalein 
treatments (50 and 100 ^iM) and actinomycin D (10 |ag/ml) for positive control. 
Since there was no DNA laddering observed even for the positive control, 
enzymatic in situ labeling of 3，-OH ends of fragmented DNA by TUNEL assay was 
performed to demonstrate whether baicalein could induce DNA fragmentation by 
flow cytometry. 
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Lane 1: 1 kbp DNA marker 
Lane 2: DMSO (negative control) 
Lane 3: 50 pM Baicalein 
Lane 4: 100 pM Baicalein 
Lane 5: 10 pg/ml Actinomycin D (positive control) 
Figure 5-9. Gel Photo for DNA Fragmentation. U87-MG cells were treated with 
control vehicle (DMSO) or indicated concentrations of baicalein for 48-h. After 
treatment, DNA fragments were isolated and run at 1.5% gel as described in Methods 
(Section 5.2.6). 
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5.3.6. Effects of Baicalein on TUNEL Assay 
Baicalein induced DNA fragmentation in a dose- and time-dependent 
manner detected by TUNEL assay. 
At 24-h treatment, there was an increase of fluorescent signal, which 
indicated the extent of DNA fragmentation, from 55.13 土 3.53o/o，61.25 土 6.02o/o, 
66.20 土 4.42% and 68.73 土 2.26o/o for 50，100，150 and 200 ^M baicalein treatments, 
respectively. 
At 30-h treatment, the fluorescent signal increased from 59.84 土 6.63Q/o， 
68.92 土 13.48%，73.54 士 12.88% and 78.73 土 11.80o/o for 50，100, 150 and 200 |uM 
baicalein treatments, respectively. 
At 48-h treatment, the fluorescent signal increased from 69.06 土 8.63%， 
91.17 土 2.76%, 93.15 土 0.89% and 98.25 土 2.00% for 50，100，150 and 200 )iM 
baicalein treatments, respectively. 
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Figure 5-10. Effect of Baicalein on TUNEL Assay. U87-MG cells were treated with 
control vehicle (DMSO) or indicated concentrations of baicalein for corresponding 
period of time. After treatment, the cells were fixed and FLl green fluorescence 
signals were measured by flow cytometry as described in Methods (Section 5.2.7). 
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Figure 5-11. Prism Analysis for TUNEL Assay. Results were expressed as the mean 
values (n=3) and error bars represented standard deviations. Statistical analysis were 
performed with one-way ANOVA followed by Tukey's Multiple Comparison Test. 
* P-value < 0.05, ** P-value < 0.01，*** P-value < 0.001 as compared with the 
control in the same treatment group. 
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5.4. Discussion 
Apoptosis can be regulated at multiple levels. A number of regulatory 
proteins related to cell death are sensitive to cellular redox state. GSH plays a key 
role in the regulation of the redox state of specific thiol residues of target proteins 
including stress kinases, transcriptional factors and apoptosis effectors. In addition, 
mitochondrial GSH is important to maintain the integrity of mitochondrial proteins 
and lipids so as to prevent permeabilization of mitochondrial membrane and release 
of pro-apoptotic proteins (Femandez-Checa, 2003). 
The apoptotic results clearly showed that baicalein induced changes in 
mitochondrial membrane potential at 16-h and phosphatidylserine exposure at 24-h 
in U87-MG cells, which are the early features of apoptosis. Since baicalein only 
slightly affected the cell cycle, the details of late apoptotic pathways instead of the 
regulation of cell cycle checkpoint were further investigated. 
Baicalein activated the initiators caspase-8 and -9 and the final executor 
caspase-3 in a dose- and time-dependent manner. Baicalein caused a large DNA 
fragment of 3500 bp but not DNA laddering. It was reported that ROS producers or 
GSH-depleting agents caused DNA fragmentation with larger chromosomal DNA 
fragments instead of DNA laddering with a variety of DNA fragments (Higuchi, 
2003). Nevertheless, TUNEL assay was performed to further confirm whether 
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baicalein could induce DNA fragmentation. It was shown that baicalein treatments 
led to dose- and time-dependent increases of the fluorescent signals indicating that 
baicalein induced DNA fragmentation. 
In summary, baicalein caused U87-MG astrocytoma cell death by induction 
of apoptosis. 
Since there were a number of reports showing that ROS generation caused 
GSH depletion resulting in apoptosis induction, it is interesting to investigate 
whether baicalein could also generate cellular and mitochondrial ROS in U87-MG 
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Chapter 6 Pro-Oxidant Role of Baicalein on Reactive 
Oxygen Species Generation 
6. Baicalein Generated Reactive Oxygen Species (ROS) 
6.1. Introduction 
It is well known that glutathione plays an important role in regulation of 
cell proliferation ad cell death. From the previous findings, baicalein was found to 
efficiently depleted GSH from 30 h onwards, which may contribute to induction of 
apoptosis in human astrocytomas. However, baicalein-induced change in 
mitochondrial membrane potential, phosphatidylserine exposure and caspase 
activation were started to be observed at 16-24 h，therefore, it was interesting to 
investigate whether baicalein could generate ROS resulting in GSH depletion and 
subsequently lead to cancer cell death. 
6.2. Materials and Methods 
6.2.1. Chemicals 
Fluorescent dyes cDCFDA and Rh.l23 were obtained from Molecular 
Probes (Eugene, USA). 
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6.2.2. Determination of Cellular Reactive Oxygen Species Generation by 
Fluorescent Dye cDCFDA 
Cellular ROS is determined by the fluorescence signals resulting from 
intracellular probe oxidation, which is then monitored by flow cytometry. cDCFDA 
(Molecular Probes, Eugene, USA) is able to penetrate cells and the acetate group on 
cDCFDA is cleaved by cellular esterases, trapping the non-fluorescent residue inside, 
which can then be oxidized by ROS including superoxide radicals and/ or hydroxyl 
radical to yield fluorescent signals. Therefore, the fluorescence intensity is 
proportional to the ROS produced by cells. 
Cells (U87-MG) were seeded in a 6-well plate (2 x cells/well) and 
allowed to grow overnight (24 h) to achieve about 90% confluence. The cells were 
treated with control vehicle (DMSO) or baicalein with different concentrations for 
different periods of time. The cells were incubated with cDCFDA (final 
concentration 10 |iM) in serum-free medium in dark at 37°C for 30 min. About 1 x 
10^  cells were collected by trypsinization and the cell pellets were washed with PBS 
once and resupsended in PBS. The green fluorescence signal (FLl) was acquired in a 
histogram. 
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6.2.3. Determination of Mitochondrial Reactive Oxygen Species Generation by 
Fluorescent Dye Rhl23 
Rhl23 works similarly as cDCFDA but it is capable of penetrating 
mitochondrial membrane for detection of mitochondrial ROS generation. Cells 
(U87-MG) were seeded in a 6-well plate (2 x lO"^  cells/well) and allowed to grow 
overnight (24 h) to achieve about 90% confluence. The cells were treated with 
control vehicle (DMSO) or baicalein with different concentrations for different 
periods of time. About 1 x 10^  cells were collected by trypsinization and the cell 
pellets were washed with PBS once and resupsended in PBS. The cells were 
incubated with Rhl23 (final concentration 10 )LIM) in PBS in dark at 37°C for 30 min. 
The green fluorescence signal (FLl) was acquired in a histogram. 
124 
Chapter 6 Pro-Oxidant Role of Baicalein on Reactive Oxygen Species Generation 
6,3. Results 
6.3.1. Effects of Baicalein on Cellular ROS Generation by Fluorescent Dye 
cDCFDA 
Cellular and mitochondrial ROS generations were determined to investigate 
whether baicalein-induced apoptosis on U87-MG cells could also correlate with its 
ability to produce ROS. 
Oxidation of cDCFDA was first detected after 6 h incubation with baicalein 
while no fluorescence signals were detected for 1, 2 and 4 h treatments (data not 
shown). After 6-h and 16-h incubation with baicalein, the fluorescence signals of 
H2O2 indicator cDCFDA markedly increased in a dose-dependent manner, an 
increase even greater than that observed after incubated with H2O2 (80 }aM) (Figure 
6-1 and Figure 6-2). Since the dramatic decrease in GSH levels was observed after at 
least 30 h incubation with baicalein, suggesting that ROS generation preceded GSH 
depletion by baicalein treatment. 
These demonstrated that baicalein generated cellular ROS, particularly 
H2O2, due to the higher affinity of cDCFDA towards H2O2 at the early stage of 
treatment (i.e. 6-h). 
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In order to further investigate whether baicalein could cause cell death by 
ROS generation and/or GSH depletion, the reversibilities of baicalein-induced GSH 
depletion and cell death by different antioxidants (sulfhydryl-containing antioxidants 
such as NAC and GEE and free radical scavengers such as CAT and SOD) were 
investigated in the next chapter. 
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Figure 6-1. Generation of Cellular ROS by Baicalein in U87-MG Cells. The cells 
were treated with control vehicle (DMSO) or indicated concentrations of baicalein 
for corresponding period of time. After treatment, the green fluorescence signals 
(FLl) were measured by flow cytometry as described in Methods (Section 6.2.2). 
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Figure 6-2. Prism Analysis for Baicalein-Induced Cellular ROS Generation. Results 
were expressed as the mean values (n=3) and error bars represented standard 
deviations. Statistical analysis were performed with one-way ANOVA followed by 
Tukey's Multiple Comparison Test. * P-value < 0.05，** P-value < 0.01, *** P-value 
< 0.001 as compared with the control in the same treatment group. 
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6.3.2. Effects of Baicalein on Mitochondrial ROS Generation by Fluorescent 
Dye Rhl23 
The increased fluorescent signal of mitochondrial ROS indicator Rhl23 
was first detected after 16 h incubation with baicalein, while no significant 
fluorescence signal changes were detected for 6-, 8- and 12-h treatments (data not 
shown). After 16-h and 24-h incubated with baicalein, the fluorescent signals of 
Rhl23 markedly increased in a dose-dependent manner (Figure 6-3 and Figure 6-4). 
At 16-h treatment, the fluorescent signals increased from 55.58 土 0.25o/o, 
64.90 土 1.12%，65.16 土 0.86o/o and 75.40 土 2.21o/o for 50，100, 150 and 200 |aM 
baicalein. 
At 24-h treatment, the fluorescent signals increased from 57.45 土 1.63o/o, 
63.48 土 3.060/0，67.01 土 1.46% and 76.78 士 1.13O/O for 50, 100, 150 and 200 |LIM 
baicalein. 
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Figure 6-3. Generation of Mitochondiral ROS by Baicalein in U87-MG Cells. The 
cells were treated with control vehicle (DMSO) or indicated concentrations of 
baicalein for corresponding period of time. After treatment, the green fluorescence 
signals (FLl) were measured by flow cytometry as described in Methods (Section 
6.2.3). 
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Figure 6-4. Prism Analysis for Baicalein-induced Mitochondrial ROS Generation. 
Results were expressed as the mean values (n=3) and error bars represented standard 
deviations. Statistical analysis were performed with one-way ANOVA followed by 
Tukey's Multiple Comparison Test. * P-value < 0.05, ** P-value < 0.01，*** ？-value 
< 0.001 as compared with the control in the same treatment group. 
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6.4. Discussion 
Significant increases in cellular and mitochondrial ROS may lead to cellular 
damage, including lipid peroxidation, oxidative DNA modifications, protein 
oxidation and enzyme inactivation and can ultimately result in cell death if the ROS 
stress is severe and persistent. 
Baicalein generated cellular and mitochondrial ROS in a dose- and 
time-dependent manner. The time for generation of cellular ROS was shorter (i.e. 6 h) 
than that for mitochondrial ROS (i.e. 16 h) and baicalein depleted GSH at 30-h 
suggesting that baicalein first generated cellular ROS and then mitochondrial ROS 
resulting in GSH depletion. 
It was demonstrated that baicalein could generate reactive oxygen species 
and deplete glutathione as well as induce apoptosis in U87-MG cells (human 
astrocytomas). Since GSH depletion and/or ROS generation could result in apoptosis, 
we are interested to investigate whether baicalein induces apoptosis via GSH 
depletion and/or ROS generation. 
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Chapter 7 The Anticancer Mechanistic Study of Baicalein 
7. Baicalein Induced Astrocytoma Cell Death Via A Pro-Oxidant 
Mechanism 
7.1. Introduction 
To investigate whether baicalein induces apoptosis via GSH depletion 
and/or ROS generation, one of the approaches was to reverse the cell death by 
different antioxidants: thiol-containing antioxidants and free radical scavengers. 
Thiol-containing antioxidants including GEE and NAC were used to 
determine whether they could alleviate baicalein-induced cell death by GSH 
depletion because GEE and NAC were found to increase intracellular GSH in both 
neuroblastoma and astrocytomas. In contrast, GSH is impermeable to astrocytes (Im 
et al.’ 2006) and GSH supplement may induce feedback inhibition on GCS for GSH 
synthesis resulting in a decrease in GSH levels. NAC is an acetylated analog of 
cysteine that easily passes through the cell membrane and is rapidly deacetylated 
inside the cell and utilized for GSH synthesis. GEE is an esterified form of GSH that 
is able to cross the cell membrane against the concentration gradient. 
Free radical scavengers including CAT and SOD were used to determine 
whether they could abrogate the baicalein-induced cell death by ROS generation. 
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7.2. Materials and Methods 
7.2.1. Chemicals 
Caspase-3, -8 and -9 inhibitors were purchased from Merck Biosciences Inc. 
(Germany). 
7.2.2. Reversibility of Baicalein-induced GSH Depletion and Cell Death by 
Different Antioxidant Treatments 
Five thousand cells per well were plated in 96-well plates and allowed to 
grow overnight (24 h) to achieve about 80% confluence. For pre-treatment 1 h prior 
to control vehicle (DMSO) or baicalein treatment, NAC (final concentration 5 mM) 
and GEE (final concentration 5 mM) in complete culture medium were added to cells 
and incubated at 37°C in a humidified atmosphere of 5% CO2 and 95% air for 1 h. 
After pre-treatment, the cells were treated with DMSO or baicalein (final 
concentration 50 |aM). For co-treatment, NAC (final concentration 5 mM), GEE 
(final concentration 5 mM), CAT (final concentration 500 unit/ml) and SOD (final 
concentration 500 unit/ml) together with baicalein (final concentration 50 ^M) were 
added to the cells. For post-treatment at 4 h or 24 h, after DMSO or baicalein 
treatment for 4 h or 24 h，NAC (final concentration 5 mM), GEE (final concentration 
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5 mM), CAT (final concentration 500 unit/ml) and SOD (final concentration 500 
unit/ml) were added. The GSH levels and cell proliferation were simultaneously 
determined by fluorescent CMAC and MTT assays in a 24-h interval for 72 h for 
each treatment (see Section 3.2.6 and 4.2.5). 
For GSH level, 
Fluorescent signal samples at corresponding periods of time 
% of control = ：； X 100% 
Fluorescent signal control at o hr 
For cell proliferation, 
O D samples at corresponding periods of time 
% of control = ~ ~ X 100% 
O D control at 0 hr 
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7.2.3. Reversibility of Baicalein-induced Cellular ROS Generation by 
Co-Treatment of Different Antioxidants 
Cells (U87-MG) were seeded in a 6-well plate (2 x 10^ cells/well) and 
allowed to grow overnight (24 h) to achieve about 90% confluence. The cells were 
treated with control vehicle (DMSO) or baicalein with different concentrations in the 
presence of different antioxidants, NAC (final concentration 5 mM), CAT (final 
concentration 500 unit/ml) and SOD (final concentration 500 unit/ml) for 48 h. The 
cells were incubated with cDCFDA (final concentration 10 [iM) in serum-free 
medium in dark at 37°C for 30 min. About 1 x 10^ cells were collected by 
trypsinization and the cell pellets were washed with PBS once and resupsended in 
PBS. The green fluorescence signal (FLl) was acquired in a histogram. 
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7.2.4. Reversibility of Baicalein-induced Apoptosis by Co-Treatment of 
Different Antioxidants and Caspase Inhibitors 
U87-MG cells were plated at a density of 2 x cells per well (5 ml/well) 
into a 6-well plate and allowed to grow overnight (24 h) to achieve 90% confluence. 
The cells were treated with control vehicle (DMSO) or baicalein with different 
concentrations in the presence of different antioxidants, GEE (final concentration 5 
mM), NAC (final concentration 5 mM), CAT (final concentration 500 unit/ml) and 
SOD (final concentration 500 unit/ml) and caspase inhibitors (final concentration 30 
|aM) for 48 h. After treatment, about 1 x 10^  cells were collected by trypsinization 
and the cell pellets were washed with PBS once and resupsended in 500 [i\ annexin V 
binding buffer containing 494 [il annexin V binding buffer, 5 |al annexin V-GFP and 
1 propidium iodide (2 mg/ml). The cell suspensions were stained at room 
temperature for 15 min. The green (FLl) and orange fluorescence (FL3) signals were 
acquired in a dot-plot. 
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7.2.5. Reversibility of Baicalein-Induced Caspase-3, -8 and -9 Activations by 
Co-Treatment of Different Antioxidants 
Cells (U87-MG) were seeded in a 6-well plate (2 x 10^ cells/well) and 
allowed to grow overnight (24 h) to achieve about 90% confluence. The cells were 
treated with control vehicle (DMSO) or baicalein with different concentrations in the 
presence of different antioxidants, NAC (final concentration 5 mM), CAT (final 
concentration 500 unit/ml) and SOD (final concentration 500 unit/ml) for 24 or 30 h. 
After drug treatment, 10 |il 3 OX working FAM-peptide-FMK solution was added to 
440 \il serum-free medium and directly added to each well. The cells were incubated 
at 37°C, 5% CO2 for 1 h in dark. About 1 x 10^  cells were washed with 1 ml IX 
working dilution washing buffer once. The cells were collected by trypsinization and 
the cell pellets were washed with 1 ml IX working dilution washing buffer twice and 
resupsended in 500 [l\ working dilution washing buffer. The signal for green 
fluorescence (FLl) was acquired in a histogram. 
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7.3. Results 
7.3.1. Reversibility of Baicalein-induced GSH Depletion and Cell Death by 
Different Antioxidant Treatments 
7.3.1.1. Pre-treatment 
Since it was reported that pre-treatment of extracellular CAT and SOD 
could down-regulate their endogenous expression and results in cells more 
susceptible to ROS. Therefore, only GEE and NAC were used in the pre-treatment 
conditions. 
Figure 7-1 showed that pre-treatment of GEE (5 mM) or NAC (5 mM) 
alone did not cause GSH depletion or cell death throughout the 72-h treatment. 
Baicalein (50 [iM) alone depleted GSH levels to 15% and decreased cell proliferation 
to 50% at 48-h treatment. This demonstrated that GEE or NAC alone at that 
concentration (5 mM) would not cause any cytotoxic effects on U87-MG cells. 
However, the pre-treatment of GEE or NAC with baicalein caused a sharp reduction 
on GSH levels and cell proliferation. This showed that pre-treatment of thiol 
antioxidants could not abrogate baicalein-induced GSH depletion and cell death and 
this was probably due to the down-regulation of GSH synthesis by thiol antioxidants 
in U87-MG cells. 
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Figure 7-1. Reversibility of Pre-Treatment of Different Antioxidants 1 h Prior to 
Baicalein Treatment on Baicalein-Induced (a) GSH Depletion and (b) Cell Death of 
U87-MG Cells. The cells were treated with different antioxidants. After 1-h 
pre-treatment, the cells were treated with control vehicle (DMSO) or indicated 
concentrations of baicalein for 72 h. The intracellular GSH levels were determined 
by CMAC as described in Methods (Section 4.2.5) while the cell proliferation was 
determined by MTT as described in Methods (Section 3.2.6) simultaneously. 
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7.3.1.2. Co-treatment 
Figure 7-2 showed that co-treatment of GEE and NAC with baicalein 
completely abrogated baicalein-induced GSH depletion and cell death throughout the 
48-h treatment. At 72-h, thiol antioxidants still exerted a partial protection that GEE 
increased GSH level from 5% to 75% and cell proliferation from 10% to 70%. NAC 
increased GSH level from 5% to 65% and cell proliferation from 10% to 60%. 
Co-treatment of CAT (500 unit/ml) and SOD (500 unit/ml) alone did not 
cause GSH depletion or cell death throughout the 72-h treatment (data not shown). 
Figure 7-3 showed that co-treatment of CAT and SOD with baicalein also completely 
alleviated baicalein-induced GSH depletion and cell death throughout the 48-h 
treatment. At 72-h, free radical scavengers also exerted a partial protection that CAT 
increased GSH level from 5% to 75% and cell proliferation from 10% to 50%. SOD 
increased GSH level from 5% to 40% and cell proliferation from 10% to 50%. 
GPx has no protective effect against ROS under the condition of GSH 
depletion as it depends on GSH. In our study, ebselen in the presence of GSH, which 
resembles GPx, could not abolish baicalein-induced GSH depletion and cell death 
(data not shown). This may be due to its high toxicity towards U87-MG cells, even at 
a low concentration of 2 
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Figure 7-2. Reversibility of Co-Treatment of Different Sulfhydryl-Containing 
Antioxidants on Baicalein-induced (a) GSH Depletion and (b) Cell Death of 
U87-MG Cells. The cells were treated with control vehicle (DMSO) or indicated 
concentrations of baicalein in the presence of sulfhydryl-containing antioxidants for 
72 h. The intracellular GSH levels were determined by CMAC as described in 
Methods (Section 4.2.5) while the cell proliferation was determined by MTT as 
described in Methods (Section 3.2.6) simultaneously. 
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Figure 7-3. Reversibility of Co-Treatment of Different Free Radical Scavengers on 
Baicalein-induced (a) GSH Depletion and (b) Cell Death ofU87-MG Cells. The cells 
were treated with control vehicle (DMSO) or indicated concentrations of baicalein in 
the presence of free radical scavengers for 72 h. The intracellular GSH levels were 
determined by CMAC as described in Methods (Section 4.2.5) while the cell 
proliferation was determined by MTT as described in Methods (Section 3.2.6) 
simultaneously. 
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7.3.1.3. Post-treatment 
For post-treatment at 4 h shown in Figure 7-4, GEE, NAC, CAT, but not 
SOD could completely abolish baicalein-induced GSH depletion throughout 72-h 
treatment. However, the antioxidants just partially reversed baicalein-induced cell 
death at the end of the treatments. 
For post-treatment at 24 h shown in Figure 7-5, there were similar 
observations that GEE, NAC, CAT and SOD could abolish baicalein-induced GSH 
depletion throughout 72-h treatment. However, the antioxidants just reduced 
baicalein-induced cell death to some extent at the end of the treatments. These were 
also consistent to caspase-3 activation results. Since caspase-3 was activated by 
baicalein within 24-h, it was reasonable that post-treatment of antioxidants at 24-h 
could not protect U87-MG cells against baicalein treatment. 
In summary, co-treatment of different antioxidants could abrogate 
baicalein-induced GSH depletion and cell death with different extents for different 
treatments. However, thiol antioxidants including GEE and NAC, in general, 
possessed a higher protective effect for baicalein treatment than CAT and SOD. 
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Figure 7-4. Reversibility of Post-Treatment of Different Antioxidants at 4 h on 
Baicalein-Induced (a) GSH Depletion and (b) Cell Death of U87-MG Cells. The cells 
were treated with control vehicle (DMSO) or indicated concentrations of baicalein. 
After 4-h treatment, the cells were treated with different antioxidants for 72 h. The 
intracellular GSH levels were determined by CMAC as described in Methods 
(Section 4.2.5) while the cell proliferation was determined by MTT as described in 
Methods (Section 3.2.6) simultaneously. 
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Figure 7-5. Reversibility of Post-Treatment of Different Antioxidants at 24 h on 
Baicalein-induced (a) GSH Depletion and (b) Cell Death of U87-MG Cells. The cells 
were treated with control vehicle (DMSO) or indicated concentrations of baicalein. 
After 24-h treatment, the cells were treated with different antioxidants for 72 h. The 
intracellular GSH levels were determined by CMAC as described in Methods 
(Section 4.2.5) while the cell proliferation was determined by MTT as described in 
Methods (Section 3.2.6) simultaneously. 
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7.3.2. Reversibility of Baicalein-Induced Cellular ROS Generation by 
Co-Treatment of Different Antioxidants 
The prevention of a decrease in GSH levels by both thiol antioxidants and 
free radical scavengers led to an investigation of alleivateing ROS generation in 
baicalein-treated U87-MG cells by antioxidants. From Figures 7-6 and 7-7, baicalein 
alone (50 jiM) increased ROS fluorescence signals to 78.96 土 1.38%. NAC (5 mM) 
could completely abolished baicalein-induced ROS generation at 6-h to 49.45 土 
1.73% while CAT (500 U/ml) and SOD (500 U/ml) partially reversed the ROS 
generation at 6-h to 69.49 土 1.96o/o and 70.85 土 2.19%, respectively. For 16-h 
treatment, NAC only slightly reduced the ROS generation by 10%, while there were 
no observable changes in the co-treatment of CAT and SOD, even for higher 
concentration of NAC (lOmM), CAT (1000 U/ml) and SOD (1000 U/ml) for 16-h 
treatment (data not shown). 
Our results demonstrated that NAC (5 mM) completely prevented the 
increase in cDCFDA fluorescence in baicalein-treated U87-MG cells at 6 h while just 
prevented the fluorescence increase by around 10% at 16 h. At 6-h treatment, CAT 
and SOD just partially prevented the fluorescence increase by around 10%, while no 
significant reduction at 16-h was observed. This may suggest that baicalein-induced 
ROS generation was only the upstream of the cell death induction process and the 
147 
Chapter 7 The Anticancer Mechanistic Study of Baicalein 
antioxidants abolished the cell death not due to scavenging free radicals. 
NAC was found to be more efficient to reverse baicalein-induced ROS 
generation than CAT or SOD. This may be because NAC can readily pass through 
cell membrane and release intracellularly for GSH synthesis. In contrast, CAT and 
SOD are incapable of passing through cell membrane and they could only scavenge 
extracellular ROS. 
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Figure 7-6. Reversibility of Co-Treatment of Different Antioxidants on 
Baicalein-induced Cellular ROS Generation of U87-MG Cells. The cells were 
treated with control vehicle (DMSO) or indicated concentrations of baicalein with 
co-treatment of different antioxidants (a) for 6-h treatment, (b) 16-h treatment. After 
treatment, the green fluorescence signals (FLl) were measured by flow cytometry as 
described in Methods (Section 6.2.2). 
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Figure 7-7. Prism Analysis for Reversibility of Co-Treatment of Different 
Antioxidants on Biacalein-Induced Cellular ROS Generation. Results were expressed 
as the mean values (n=3) and error bars represented standard deviations. Statistical 
analysis were performed with one-way ANOVA followed by Tukey's Multiple 
Comparison Test. * 尸-value < 0.05，** 尸-value < 0.01，*** 户-value < 0.001 as 
compared with the control vehicle in the same treatment group. ### 户-value < 0.001 
as compared with baicalein alone (50 [iM) in the same treatment group. 
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7.3.3. Reversibility of Co-Treatment of Different Antioxidants and Caspase 
Inhibitors on Baicalein-induced Apoptosis 
To determine whether the activation of caspases is essential for the 
induction of apoptosis by baicalein, caspase inhibitors were used to reverse 
baicalein-induced apoptosis by annexin V-propidium iodide assay. As shown in 
Figure 7-8 and Figure 7-9, GEE (5 mM), NAC (5 mM), CAT (500 unit/ml), SOD 
(500 unit/ml) and caspase-8 and -9 inhibitors (30 |nM) but not caspase-3 inhibitor (30 
pM)，effectively prevented phosphatidylserine exposure, which was an early 
hallmark of apoptosis, in baicalein-treated U87-MG cells. 
By directly determining apoptosis using annexin V-propidium iodide assay, 
baicalein (50 )LIM) alone induced 19.64% cells to undergo apoptosis, while it induced 
apoptosis in only 7.58% and 8.17% cells in the presence of NAC and GEE, 
respectively. In addition, in the presence of CAT and SOD, the percentages of 
baicalein-induced apoptotic cells were 13.02% and 12.18%, respectively. This 
demonstrated that NAC and GEE significantly while CAT and SOD partially 
abolished baicalein-induced apoptosis. 
Caspase-8 and -9 inhibitors could also significantly reduce 
baicalein-induced apoptosis to 11.76% and 13.49%, respectively. The observed 
apoptotic cells stained by annexin V was insensitive to caspase-3 inhibitor (30 |jM), 
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even at a higher concentration of 50 |LIM, at which alone did not affect the cell 
proliferation (data not shown). To further investigate whether baicalein-induced 
apoptosis dependent or independent of caspase pathways, reversibilities of 
co-treatment of different antioxidants on baicalein-induced caspase activations were 
performed. 
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Figure 7-8. Reversibility of Co-Treatment of Different Antioxidants and Caspase 
Inhibitors on Baicalein-Induced Apoptosis by Annexin V-Propidium Iodide Staining, 
(a) DMSO acts as a negative control, (b) 50 [xM B, (c) 50 )iM B + 5 mM NAC, (d) 
50 laM B + 5 mM GEE, (e) 50 )iM B + 500 unit/ml CAT, (f) 50 jLiM B + 500 unit/ml 
SOD, (g) 50 |iM B + 30 [M caspase- 3 inhibitor, (h) 50 |aM B + 30 |iM caspase-8 
inhibitor, (i) 50 jiiM B + 30 \xM caspase-9 inhibitor. 
154 
Chapter 7 The Anticancer Mechanistic Study of Baicalein 
2 0 ] 
o “ T ** 
• 一 * * * * * ！iJiiiil 
DMSO I + I 
50 \M B + + + + + + + + 
5mM NAC + 
5 mM GEE + 
500 U/ml CAT + 
500 U/ml SOD ； 
30|LiM cas-3 I + 
30 |uM cas-8 I + 
30 MM cas-9 I + 
Figure 7-9. Prism Analysis for Reversibility of Co-Treatment of Different 
Antioxidants and Caspase Inhibitors on Baicalein-induced Apoptosis at 48-h. Results 
were expressed as the mean values (n=3) and error bars represented standard 
deviations. Statistical analysis were performed with one-way ANOVA followed by 
Tukey's Multiple Comparison Test. * value < 0.05，** P-value < 0.01, *** 尸-value 
< 0.001 as compared with baicalein alone (50 laM). 
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7.3.4. Reversibility of Baicalein-induced Caspase-3 Activation by 
Co-Treatment of Different Antioxidants 
Figure 7-10 and figure 7-11 showed that both thiol antioxidants and free 
radical scavengers could significantly abrogated baicalein-induced caspase-3 
activation. 
At 24 h, baicalein-induced caspase-3 activation could be abolished by 
different antioxidants with the decreasing order of efficacies: GEE > NAC � S O D > 
CAT while 30-h treatment showed similar results as the order of efficacies: GEE > 
NAC > SOD > CAT. However, only GEE could exert the protective effect at 48-h. 
From the above results, thiol antioxidants (NAC and GEE) were found to 
be more effective then free redical scavengers to abolish baicalein-induced caspase-3 
activation. 
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Figure 7-10. Reversibility of Co-Treatment of Different Antioxidants on 
Baicalein-Induced Caspase-3 Activation of U87-MG Cells at 24, 30 and 48 h. The 
cells were treated with control vehicle (DMSO) or indicated concentrations of 
baicalein with co-treatment of different antioxidants for 24-, 30- and 48-h treatments. 
After treatment, the green fluorescence signals (FLl) were measured by flow 
cytometry as described in Methods (Section 5.2.6). 
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Figure 7-11. Prism Analysis for Reversibility of Co-Treatment of Different 
Antioxidants on Baicalein-induced Caspase-3 Activation of U87-MG Cells at 24-, 
30- and 48-h. Results were expressed as the mean values (n=3) and error bars 
represented standard deviations. Statistical analysis were performed with one-way 
ANOVA followed by Tukey's Multiple Comparison Test. * P-value < 0.05, ** 
尸-value < 0.01, *** 尸-value < 0.001 as compared with baicalein alone (50 juM). 
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7.3.5. Reversibility of Baicalein-induced Caspase-8 and -9 Activation by 
Co-Treatment of Different Antioxidants 
Since baicalein only significantly activated caspase-8 and -9 at 30-h, 
reversibility of co-treatment of antioxidants on caspase-8 and -9 activations were 
only focused on 30-h treatment. 
Figure 7-12 and Figure 7-13 showed that baicalein-induced caspase-8 and 
-9 activations could be abolished by different antioxidants with the decreasing order 
of efficacies: GEE > NAC > SOD > CAT, which was the same order as the results for 
caspase-3. GEE, NAC, SOD and CAT could reduce the caspase activation by 34%, 
32%, 16% and 27%, respectively. 
However, only thiol antioxidants could significantly abrogated caspase-9 
activation. GEE and NAC could reduce the caspase activation by 33% and 33% 
respectively. Figure 7-13 showed that free radical scavengers did not exert a dramatic 
protective effect on caspase-9 activation. 
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Figure 7-12. Reversibility of Co-Treatment of Different Antioxidants on 
Baicalein-induced (a)Caspase-8 and (b)Caspase-9 Activation of U87-MG Cells. The 
cells were treated with control vehicle (DMSO) or indicated concentrations of 
baicalein with co-treatment of different antioxidants for 30-h treatment. After 
treatment, the green fluorescence signals (FLl) were measured by flow cytometry as 
described in Methods (Section 5.2.6). 
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Figure 7-13. Prism Analysis for Reversibility of Co-Treatment of Different 
Antioxidants on Baicalein-induced Caspase-8 and -9 Activation of U87-MG Cells at 
30-h. Results were expressed as the mean values (n=3) and error bars represented 
standard deviations. Statistical analysis were performed with one-way ANOVA 
followed by Tukey's Multiple Comparison Test. * P-value < 0.05, ** P-value < 0.01, 
*** P-value < 0.001 as compared with baicalein alone (50 )LIM). 
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7.4. Discussion 
Since baicalein could generate ROS and deplete GSH, we suggested that 
different antioxidants (thiol antioxidants and free radical scavengers) with different 
treatments (pre-, co- and post-treatments) might abolish baicalein-induced cell death. 
7.4.1. Reversibility of Baicalein-induced GSH Depletion and Cell Death 
Pre-Treatment 
It was shown that pre-treatment with exogenous CAT or SOD might 
down-regulate endogenous enzyme expression and render GSH-depleted cells more 
susceptible for effects of endogenous ROS to apoptosis (Schimmel and Bauer, 2002). 
Therefore, only pre-treatments of GEE and NAC were performed. 
It was a general phenomenon that pre-treatment of astrocytes with NAC 
and GEE may increase intracellular GSH to 179% of the control (Im et al., 2006). 
This may explain the dramatic increase of GSH levels at the early stage (i.e. 24 h) of 
thiol antioxidant additions. 
However, GSH depletion and cell death induction could not be prevented 
by pre-treatment of thiol antioxidants, either. This may be also due to the 
pre-conditioning effect of pre-treatment of GEE or NAC, which resulted in feedback 
inhibition of GSH synthesis and thus U87-MG cells were more susceptible to 
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baicalein treatment. Therefore, the subsequent experiments for reversibility of 
baicalein-induced GSH depletion and cell death were focused on co-treatment and 
post-treatment. 
Co-Treatment 
Co-treatment of GEE, NAC, CAT and SOD could completely abolished 
GSH depletion and cell death induction within 48-h treatment However, it only 
exerted a partial protection at 72 h. This may be due to exhaustion of antioxidants 
applied. 
Thiol antioxidants were found to be more protective in baicalein treatment. 
This may be because thiol antioxidants used were more readily across the cell 
membrane than free radical scavengers. Since exogenous catalase and superoxide 
dismutase cannot penetrate cellular membranes, their actions are restricted to 
detoxification of extracellular ROS. Baicalein-induced cell death was inhibited by 
co-treatment of CAT and SOD, suggesting that exogenous ROS might also be 
responsible for induction of cell death in U87-MG cells. 
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Post-Treatment 
Both post-treatment of thiol antioxidants and free radical scavengers could 
completely reverse baicalein-induced GSH depletion and GSH levels remained high 
throughout the 3-day treatment. However, the antioxidants only partially reverse cell 
death. This showed that replenishment of GSH or reduction of ROS generation after 
baicalein treatment could not help in abolishment of baicalein-induced cell death and 
once baicalein triggered ROS generation, the effects were so devastating that the 
antioxidants were no longer protective even at the post-treatment at 4 h. Since ROS 
generation proceeded much earlier than GSH depletion, we proposed that ROS 
generation may play the key role in baicalein-induced cell death. 
In view of the fact that only co-treatment of antioxidants could protect 
U87-MG cells from baicalein-induced cell death, reversibility of ROS generation, 
apoptosis and caspase activation would be focused on co-treatment only. 
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7.4.2. Reversibility of Baicalein-Induced ROS Generation, Apoptosis and 
Caspase Activation 
Co-treatment of antioxidants could significantly eradicate cellular ROS 
generation at 6-h and co-treatment of antioxidants and caspase-8 and -9 inhibitors 
could also significantly abrogate baicalein-induced phosphatidylserine exposure at 
48-h, which is a hallmark of early apoptosis while caspase-3 inhibitors could not 
considerably eradicate the apoptotic effect of baicalein. One of the possible reasons 
was that caspase-3 is a final executor for apoptosis, even caspase-3 activation was 
suppressed by caspase-3 inhibitor, induction of phosphatidylserine may be inevitably 
triggered. Another reason was that the concentration of caspase-3 inhibitor may not 
be sufficient to abolish baicalein-induced caspase-3 activation. This was consistently 
that caspase-3 activation was reversed by antioxidants at 24- and 30-h treatments, but 
not at 48-h. when caspase-3 was once activated at 48-h. it was difficult to reverse the 
apoptotic effect. 
It was showed that both thiol antioxidants and free radical scavengers could 
abolish caspase-8 activation, but only thiol antioxidants could reduce caspase-9 
activation. This suggested that although baicalein activated both caspase-8 and -9 
pathways, caspase-8 pathway may play a more important than caspase-9 pathway. 
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7.5. Concluding Remarks 
The results presented in this study suggested that baicalein induced 
caspase-dependent astrocytoma cell death via a pro-oxidant mechanism, mainly by 
ROS generation without exerting cytotoxic effects on normal human astrocytes and 
neurons. The drug susceptibility was found to be correlated to the basal intracellular 
GSH levels in brain cells. We proposed that the sequence of events of 
baicalein-induced U87-MG cell death is as follows: generation of cellular and 
mitochondrial ROS disruption of mitochondrial membrane potential induction 
of phosphatidylserine exposure -> depletion of GSH activation of caspases -> 
DNA fragmentation. Further studies on the details of anticancer effect by baicalein 
and in vivo study are highly warranted. 
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Chapter 8 General Discussion 
8. Dual Roles of Baicalein on Brain Cells 
8.1. Drug Delivery to Brain 
It has been suggested that only small, non-ionic and lipid-soluble molecules 
can diffuse across the blood brain barrier (BBB) from the systemic circulation 
(Rautioa and Chikhale, 2004). Baicalein is low-molecular-weight pure compound 
which is highly lipid-soluble. 
Baicalein was found to be capable of penetrating BBB 20-30 min after 
administration (Tsai et al., 2002). Therefore, baicalein could be efficiently brought to 
the brain cancer cells to exert its biological actions. Some studies suggested that 
BBB is broken down during the occurrence of astrocytoma because astrocytes are 
glial cells that function as a support and key component of BBB (Lemke, 2004). 
Nevertheless, there are a number of advanced technologies for drug 
delivery to the brain such as immunoliposomes which are polyethylene glycol 
(PEG)-conjugated liposomes containing the target drug with monoclonal antibody 
against the tranferrin receptor in BBB. These immunoliposomes could be transported 
across the BBB by receptor-mediated transcytosis. In addition, implantable 
controlled-release polymers (Sipos and Brem, 2000) and magnetic microspheres are 
other strategies for drug delivery to brain cancers (Rautioa and Chikhale, 2004). 
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8.2. Protective Roles of Baicalein on Brain Cells 
8.2.1. Actions Against Oxidative Stress 
Flavonoids from Scutellaria baicalensis Georgi attenuated H202-induced 
apoptosis and protein oxidation in neuronal cell line HT-22 (Gao et al.’ 2001) and in 
neuroblastoma cell line SH-5YSY (Choi et al., 2002). Baicalein protected SH-5YSY 
neuroblastoma cell line from 6-hydroxydopamine (6-0HDA)-induced damage by the 
attenuation of ROS. 6-OHDA is a dopamine analog which readily undergoes 
non-enzymatic oxidation resulting in the production of H2O2, superoxide radical and 
hydroxyl radical under physiological conditions. Baicalein is a ROS scavenger which 
strongly inhibits 6-OHDA-induced ROS generation (Lee et aL, 2005). 
Baicalein potently inhibited lipopolysaccharide (LPS)-induced superoxide 
radical production in microglia cultures (Suk et al., 2003) and NO production in 
neuron-glial cultures (Canals et al., 2003). Baicalin also protected neurons and 
astrocytes from oxidative stress (Song et al.’ 2004). Baicalein was found to be 
neuroprotective after stroke by reducing oxidative toxicity in primary rat neurons. 
12/15-lipoxgenase (LOX) led to brain damage resulting in stroke, and therefore LOX 
inhibitor would protect against the damaging effects of stroke. Baicalein protected 
the ischemic mice through LOX inhibition by interacting directly with iron located in 
the active site of enzymes. 
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8.2.2. Actions Against Other Neurotoxic Damages 
Baicalein and baicalin increased survival of primary cultured neurons 
against glutamate- and glucose deprivation-induced neuronal death. They might 
protect neurons against glutamate excitotoxicity by attenuating intracellular calcium 
elevation, but only baicalein could protect neurons from glucose deprivation-induced 
cell death. Since baicalein and baicalin had no effect on glutamate receptor binding, 
they might reduce the increase of intracellular calcium downstream of the glutamate 
receptor activation via calcium channels or phospholipase C signaling cascade (Lee 
et «/.,2003). 
Astrocytes are one type of glial cells which protect and support neurons. 
Astrocytes have a higher antioxidant potential than neurons. Since GSH is 
predominant in astrocytes while ascorbate is predominant in neurons (Chuang and 
Chen, 2004), baicalein-induced GSH depletion may not affect neuronal survival. 
This was also shown in our study that baicalein did not significantly affect human 
neuronal cells (HCN-2) cell proliferation after 3 days of treatment. In addition, the 
anti-proliferative activity of baicalein was much lower in primary human astrocytes 
(NHA) than in cancer cells. 
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8.2.3. Actions Against Neuronal Diseases 
Recent studies showed that both baicalein and baicalin possessed protective 
effects on neuronal and glial cells. For instance, they were suggested to reduce the 
risk of Alzheimer's Diseases. Baicalein and baicalin protected dopaminergic 
neuronal cells from oxidative stress and the primary cortical neurons and PC 12 cell 
line (Heo et al, 2004) from p-amyloid peptide-induced neurotoxicity at low 
concentrations in vitro, which was demonstrated to induce Alzheimer's disease 
(Wang et al, 2004). 
Baicalein inhibited a-synuclein fibrillization by reaction of baicalein 
quinone with a lysine side chain of a-synuclein to form a SchifF base and also 
induced the disaggregation of existing fibrils (Zhu et al., 2004). Since fibrillization of 
a-synuclein formed Lewy bodies in neurons and caused degeneration of 
dopaminergic neurons resulting in Parkinson's disease, baicalein may also reduce the 
risk of Parkinson's disease by inhibition of a-synuclein fibrillization. Another study 
also suggested that baicalein attenuated inflammation-mediated degeneration of 
dopaminergic neurons by inhibiting microglial activation (Li et al, 2005). 
Baicalein administrated intraperitoneally (i.p) significantly improved 
vascular dementia-induced cognitive deficits and neuropathological changes (Liu et 
a/., 2007). 
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8.3. Anticancer Role of Baicalein on Astrocytoma 
The response of astrocytoma to chemotherapy and radiotherapy is poor. 
While Grade II astrocytomas have a median survival time about 5 years, those of 
higher grades can only survive for about 1 year (Datta et al, 2002). Therefore, there 
is an urgent need to develop a novel drug specific for astrocytomas without affecting 
normal astrocytes. 
GSH regulates cell proliferation and apoptosis as well as plays a prominent 
role in resistance against chemotherapy and radiotherapy. GSH depletion was shown 
to activate p38 MAPK or to inhibit Akt phosphorylation, which sensitized cells to 
apoptosis. GSH depletion also increased cell sensitivity to Fas-induced apoptosis. A 
decrease in GSH-triggered activation of neuronal 12-lipoxygenase would lead to the 
production of peroxides, the influx of Ca^^ and ultimately to cell death (Meurette et 
al, 2005). GSH depletion may increase the therapeutic efficacy of cancer treatment 
and overcome the chemo-resistance of cancer cells. 
Although BSO is in clinical trial for chemotherapy, previous studies 
showed that BSO inhibited GSH synthesis in liver and other peripheral organs but 
failed to suppress the level of GSH in the CNS (Slivka et al., 1988). Chronic oral 
administration of BSO to rats in their drinking water markedly lowered GSH content 
in many tissues such as liver, kidney, pancreas, lung, heart, muscle and intestinal 
173 
Chapter 8 General Discussion 
mucosa. The brain however, was resistant to systemically administered BSO. This 
might be due to either a slow turnover of GSH or inability to attain sufficiently high 
concentration of BSO in brain. 
Other studies showed that baicalein was capable of passing through BBB 
and from our study, baicalein inhibited astrocytoma cell proliferation and induced 
apoptosis in vitro with a minimal cytotoxic effect on human normal astrocytes. This 
specificity towards cancer cells may be due to the differential basal GSH levels 
between normal and cancer brain cells. 
It is important to note that specific baicalein-induced cancer cell death by 
ROS generation and GSH depletion might be restricted to cancer cells containing 
much lower GSH levels than the corresponding normal cells so as to ensure little 
cytotoxicity towards the normal cells. Some studies showed that in contrast to many 
drug-resistant cell lines, multidrug-resistant small cell lung cancer cell line H69AR, 
which was more sensitive to BSO-induced cell death，had markedly lower GSH 
levels than the drug-sensitive cell H69 (Cole et al., 1990). 
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8.4. Implications on the Dual Roles of Baicalein: Antioxidant and Pro-oxidant 
Baicalein is a well-known antioxidant. However, in our study, baicalein also 
acted as a pro-oxidant, which most probably contributed to its anticancer property. 
Some studies demonstrated that quercetin, which is a well-known antioxidant 
flavonoid, could also act as a pro-oxidant to exert its anticancer actions on leukemia 
cells (Chen and Kang, 2005). 
Flavonoids may act as pro-oxidants via interaction with transition metals. It 
was found that baicalein reduced transition metals by the action of phenolic groups 
resulting in further reduction of oxygen molecules to form superoxide radicals. 
Hydrogen peroxide and further hydroxyl radicals can be formed from superoxide 
radicals (Makino et al., 2006). 
8.5. Future Perspectives 
8.5.1. Effects of Baicalein on Antioxidant System 
It was demonstrated in our study that baicalein could induce apoptosis via a 
pro-oxidant mechanism. Baicalein generated cellular and mitochondrial ROS at the 
early stage of treatment, however, GSH depletion started to be observed at 30 h. 
Therefore, it is worthy to investigate the effect of baicalein on protein expression and 
activities of different antioxidant enzymes such as SOD, CAT and GPx in the cell 
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lines investigated. This could help to obtain a more comprehensive idea whether 
baicalein-induced ROS generation could overcome the above antioxidants resulting 
in GSH depletion. In addition, it is suggested that higher antioxidant potential of the 
cell lines might also contribute to lower susceptibility towards baicalein treatment. 
Thus, the basal levels of the above antioxidants in different cell lines should be 
determined to justify whether other antioxidant instead of GSH alone might also play 
a role in differential susceptibilities towards baicalein treatment. 
8.5.2. Effects of Baicalein on GSH Synthesis 
Basal GSH level was found to be related to drug susceptibility, however, 
GSH depletion started to be observed after induction of early apoptotic features such 
as exposure of phosphatidylserine. Therefore, it is well worth investigating the effect 
of baicalein on GSH syntheis to obtain a complete picture whether baicalein could 
also affect GSH synthesis and this may help to explain the relationship between basal 
GSH level and drug susceptibility. Since GCS is the rate limiting enzyme for GSH 
synthesis and inhibition of GCS could deplete GSH, the effects of baicalein on GCS 
protein expression and actitivies should be investigated in the future. 
Nevertheless, cystine uptake is also important for GSH synthesis because 
cystine is the rate limiting amino acid for GSH formation. Interestingly, some studies 
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demonstrated that cytine transporter was highly expressed in U87-MG but not in 
human normal neurons or astrocytes (Chung, et al,, 2005). Therefore, an 
investigation on the effect of baicalein on cytine tranporter should be performed to 
see whether baicalein could inhibit cystine transporter resulting in GSH depletion at 
the later stage. In addition, inhibition of cystine transporter might be a novel 
promising strategy to treat brain cancers since the transporter is only expressed in 
astrocytomas but not in normal brain cells (Chung, et al” 2005). Therefore, a study 
of the effects of baicalein on cystine transporter is highly recommended. 
8.5.3. In Vivo Studies on Cytotoxic Effects of Baicalein 
It was suggested that baicalein could protect cardiomyocytes from 
hypoxia/reoxygenation (Woo., et al, 2005), therefore, it is necessary to investigate 
whether baicalein could be developed as an effective anticancer drug as a adjuvant 
therapy without induction of side effects. In vivo studies on cytotoxic effects of 
baicalein on mice should be performed, for instance, the activities of aspartate 
aminotransferase (AST) and alanine aminotransferase (ALT), which are common 
indicators of liver damage; LDH，which is also used as a marker of cellular injury in 
heart, could be determined after sacrificing baicalein-treated mice. In addition, the 
highest concentration of baicalein the mice could tolerate should also be determined 
to provide some insights for pre-clinical studies. 
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8.5.4. In Vivo Studies on Anti-Tumor Effects and In Vitro Studies on 
Anti-Metastasis of Baicalein 
It was shown that baicalein could induce astrocytoma cell death by 
apoptosis in vitro in our study and secondary brain tumors were originated from 
tumors of other tissue origins (see Section 4.1.1), and since other studies suggested 
that glutathione might be related to the regulation of metastasis (see Section 1.4.6.2), 
it is well worth investigating whether baicalein might also exhibit antitumor effect in 
vivo and whether it could hamper metastasis. 
For in vivo study, xenograft tumor model could be used to investigate the 
effect of baicalein on tumor-bearing nude mice and the tumor growth could be 
determined by weight and dimension of untreated and baicalein-treated tumors 
(Fomchenko and Holland, 2006). 
To investigate the effect of baicalein on metastasis, tissue-specific 
metastasis could be generated by spontaneous or experimental metastasis from 
tumors transplanted into suitable recipient animals such as mice. Spontaneous 
metastasis involves injection of tumor cells into mammary glands resulting in the 
formation of physiologically relevenat primary tumors and subsequently leading to 
spontaneous metastasis in different distant sites. Experimental metastasis involves 
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direct introduction of tumor cells into blood circulation. The route of inoculation may 
affect the metastasis pattern, for example, lateral tail vein injection primarily 
generates pulmonary metastasis and intracardiac injection allows widespread tumor 
formation throughout the bodies of the animals and generates metastasis at multiple 
sites including brain. The cell lines for inoculation could be labeled with a firefly 
luciferase reporter and the metastasis could be visualized by bioluminescence 
imaging (Lu and Kang, 2007). The effect of baicalein on metastasis therefore could 
be determined by the comparison of bioluminescence of untreated and 
baicalein-treated mice. 
If baicalein could hamper metastasis, it is also well worth investigating the 
effect of baicalein on angiogenesis because angiogenesis, which is a process of the 
formation of new vessels from a pre-existing microvascular network, is an essential 
step for tumor growth and development of metastasis. Since dififbsion is not 
sufficient to support rapidly-growing tumor masses, expansion of solid tumor beyond 
2 mm^ requires the development of new blood vesseles (Kirsch et al, 2000) which 
are important for supplement of oxygen and nutritents, elimination of biological 
wastes and entry of cancer cells to bloodstream and metastasis to distant organs. 
Therefore, inhibition of angiogenesis could be a therapeutic approach for the 
suppression of metastasis (Tan et al., 2003; Gourley and Williamson, 2000). 
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There are several important steps for angiogenesis: endothelial cell 
proliferation and migration, formation of capillary tubes and survival of newly 
formed blood vessels. For inhibition of cell proliferation, migration and tube 
formation and the regulation of angiogenic factors by baicalein could be studied by 
MTT assay and migration of human microvascular dermal endothelial cells, tube 
formation assay, chicken chorioallantoic membrane assay and corneal micropocket 
assay (Tan et al., 2003). 
These assays may give us a more complete understanding of the anticancer 
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